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ABSTRACT 
Kirk Alan Staschke 
INTEGRATION OF GENERAL AMINO ACID CONTROL AND TOR 
REGULATORY PATHWAYS IN YEAST 
 
Two important nutrient sensing and regulatory pathways, the general amino acid 
control (GAAC) and the target of rapamycin (TOR), participate in the control of yeast 
growth and metabolism in response to changes in nutrient availability.  Starvation for 
amino acids activates the GAAC through Gcn2p phosphorylation of the translation 
initiation factor eIF2 and preferential translation of GCN4, a transcription activator.  TOR 
senses nitrogen availability and regulates transcription factors, such as Gln3p.  We used 
microarray analyses to address the integration of the GAAC and TOR pathways in 
directing the yeast transcriptome during amino acid starvation and rapamycin treatment. 
We found that the GAAC is a major effector of the TOR pathway, with Gcn4p and Gln3p 
each inducing a similar number of genes during rapamycin treatment.  While Gcn4p 
activates a common core of 57 genes, the GAAC directs significant variations in the 
transcriptome during different stresses.  In addition to inducing amino acid biosynthetic 
genes, Gcn4p activates genes required for assimilation of secondary nitrogen sources, 
such as -amino-butyric acid (GABA).  Gcn2p activation upon shifting to secondary 
nitrogen sources is suggested to occur by means of a dual mechanism.  First, Gcn2p is 
induced by the release of TOR repression through a mechanism involving Sit4p protein 
phosphatase.  Second, this eIF2 kinase is activated by select uncharged tRNAs, which 
were shown to accumulate during the shift to GABA medium.  This study highlights the 
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mechanisms by which the GAAC and TOR pathways are integrated to recognize 
changing nitrogen availability and direct the transcriptome for optimal growth adaptation. 
 
 
Ronald C. Wek, Ph.D., Chair 
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INTRODUCTION 
I. The eIF2 kinase family 
Eukaryotic cells regulate protein synthesis in response to diverse environmental 
cues by down-regulating overall translation or in some cases increasing translation of 
specific mRNAs.  This response is regulated in large part by a family of protein kinases 
that phosphorylate the eukaryotic initiation factor 2 (eIF2) on serine-51 of the alpha 
subunit (1).  Four mammalian eIF2 kinases have been identified, including the Heme 
regulated inhibitor (HRI), Double-stranded RNA activated protein kinase (PKR), 
Pancreatic eIF2 kinase (PEK) or PKR-like ER kinase (PERK), and the general control 
nonderepressible (GCN2) protein kinase (Fig. 1).  This latter kinase is expressed broadly 
among eukaryotes, including the yeast Saccharomyces cerevisiae, and will be discussed 
in much greater detail below.  This family of eIF2 kinases display extensive sequence 
homology in their catalytic kinase domains, but contain divergent regulatory regions 
outside this domain allowing for stress-specific activation of kinase function (Fig. 1). 
The eIF2 protein consists of three subunits (α, β, and ) and forms a ternary 
complex (TC) with GTP and initiator methionyl-tRNAi
Met
 facilitating binding of initiator 
tRNA to the 40S ribosomal subunit (2) and ribosomal selection of the translational start 
site (3-4).  Coupling of the 60S ribosomal subunit to form an 80S initiation complex at 
the AUG start codon proceeds with hydrolysis of GTP and release of eIF2-GDP (3).  In 
yeast and mammalian mRNAs, upstream open reading frames (uORFs) present in the 5’-
UTR of mRNAs allow for gene-specific translational control, a mechanism which will be 
discussed in further detail in below.  The eIF2-GDP is subsequently recycled back to the 
GTP bound form by the guanine nucleotide exchange factor eIF2B.  Phosphorylation of  
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Figure 1.  The eIF2 protein kinase family.  Schematic diagram of yeast GCN2, human 
PKR, rat HRI, and mouse PEK or PERK.  Conserved catalytic kinase domains are 
depicted by cross-hatched boxes.  Divergent regulatory domains which allow for stress 
specific activation of these kinases are juxtaposed to the protein kinase domain.  As 
illustrated in the figure, Gcn2p regulatory sequences include the amino terminal region 
that binds the positive regulators Gcn1p/Gcn20p, pseudo kinase domain, protein kinase 
region, HisRS-related region and the c-terminal dimerization and ribosome binding 
sequences.  PKR and HRI have dsRNA-binding motifs and heme-binding regions, 
respectively.  PERK/PEK has a transmembrane domain (TM) and a signal peptide (SP) 
sequence, which flank the ER lumenal region.  Participation of the flanking regions in the 
regulation of each eIF2 kinase is described further in the text.
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eIF2 converts eIF2-GDP from a substrate to an inhibitor of eIF2B, resulting in a 
reduction in TC levels and reduced protein synthesis (3,5). 
As mentioned above, the individual eIF2 kinases contain unique regulatory motifs 
allowing for activation of these kinases resulting in eIF2α phosphorylation in a stress-
specific fashion.  For example, reduced heme levels in erythroid cells results in activation 
of HRI,  allowing for coordinated translational synthesis of globin in accordance with 
heme availability (6-7).  Unfolded proteins in the endoplasmic reticulum activate PEK or 
PERK, considered a major effector of the unfolded protein response (UPR) pathway (8-
10).  Double-stranded RNAs present in virally infected cells result in activation of PKR 
(11-12) while starvation for amino acids, glucose, serum, or UV irradiation among other 
stresses results in activation of GCN2 protein kinase (13) (Fig. 2).  Inactivation of the 
TOR signaling pathway in yeast by the immunosuppressant drug rapamycin also results 
in activation of GCN2 protein kinase (14-16), and the biological significance of this 
regulatory pathway is a major focus of this thesis. 
 
II. The general control pathway in yeast 
Changes in nutrient availability direct programs of gene expression, which allow 
for adaptive modifications in metabolism and nutrient uptake.  Many different stress 
response pathways are thought to recognize nutritional deficiencies and contribute 
coordinately to the restructuring of the transcriptome.  An important example of such a 
stress response is the general amino acid control (GAAC) pathway.  In the GAAC, 
starvation for amino acids triggers phosphorylation of eIF2  by the protein kinase Gcn2p 
(17-19).  Ultimately this results in increased expression of a large number of genes  
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Figure 2.  The eIF2 kinases regulate translation in response to diverse 
environmental stresses.  Phosphorylation of eIF2α on Ser-51 by the various eIF2 
kinases in response to environmental stresses converts eIF2-GDP from a substrate for the 
guanine nucleotide exchange factor eIF2B to a competitive inhibitor resulting in lowered 
ternary complex levels and reduced translation initiation
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involved predominantly in metabolism of amino acids.  This has been referred to as 
cross-pathway control since the induction of genes important for the biosynthesis of 
virtually all amino acids is independent of which amino acid is limiting. 
The GAAC can be divided into three basic parts.  The first concerns the 
mechanism by which cells monitor amino acid levels.  This sensing mechanism is carried 
out by the protein kinase Gcn2p and involves direct interaction between Gcn2p and 
uncharged tRNA that accumulates in cells severely limiting for amino acids (19).  The 
second part involves elevated levels of the transcriptional activator Gcn4p in response to 
starvation for amino acids.  A central feature of this induced expression involves 
preferential translation of GCN4 mRNA, a mechanism that has become a classic example 
of gene-specific translational control.  The third part of the GAAC is the coordinate 
expression of hundreds of genes through Gcn4p-directed regulation of transcription (20).  
To mediate this regulation of mRNA synthesis, Gcn4p binds to a defined promoter 
sequence (TGABTVW), referred to as the general control response element (GCRE) and 
enhances access for the RNA polymerase II transcriptional apparatus.  This results in the 
activation of a collection of genes important for stress remedy and the salvaging of 
nutrients important for renewal.  In addition to amino acid limitation, activation of the 
GAAC pathway occurs during other environmental stress conditions including other 
nutrient limitations such as carbohydrate or purine deprivation (13).  The mechanistic 
details central to each of these parts of the GAAC will be described in detail below.  
Importantly, many of these conceptual features are conserved not only in Gcn2p-
mediated stress pathways among other eukaryotic organisms, but also more generally in 
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other stress management pathways whereby complex stress conditions are recognized and 
processed to coordinate gene expression. 
 
III. Uncharged tRNA activates Gcn2p protein kinase 
Starvation for any one of at least ten different amino acids studied induces 
expression of Gcn4p and its target genes.  Mutations in aminoacyl-tRNA synthetase 
genes, such as HTS1 important for charging of of tRNA
His
, elicit the general control 
response in yeast even in the presence of abundant cognate amino acid (21).  Hence, 
elevated levels of uncharged tRNA that accumulate during amino acid starvation are 
thought to be the direct signal that activates the general control pathway (22).  
The sensor for uncharged tRNA levels in yeast is the multi-domain protein Gcn2p 
(Figs. 1 and 3).  The central kinase domain of Gcn2p is directly involved in catalyzing the 
phosphorylation of eukaryotic initiation factor-2 (eIF2) in response to stress, an event that 
as described further below modifies the activity of this translation initiation factor and 
triggers increased Gcn4p synthesis (23).  Recognition and activation of Gcn2p by 
elevated levels of uncharged tRNA involves a regulatory domain that has sequence 
homology with almost the entire length of the histidyl-tRNA synthetase (HisRS) enzymes 
(24).  Genetic studies support the idea that the HisRS-related domain of Gcn2p 
participates in the monitoring of these starvation conditions as residue substitutions in the 
HisRS domain were shown to effect GCN4 expression.  In particular one mutant gcn2-m2 
contains residue substitutions in motif 2 (Y1119L and R1120L), a conserved region 
among class II synthetases that directly interacts with tRNA substrates (21).  The gcn2-
m2 mutant was not able to phosphorylate eIF2  and failed to induce expression of GCN4  
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Figure 3.  Uncharged tRNA activates Gcn2p protein kinase.  Uncharged tRNA binds 
to the HisRS domain in Gcn2p protein kinase resulting in activation of kinase activity.  
This stimulates phosphorylation of the eIF2α at Serine-51 converting eIF2 to a potent 
inhibitor of the guanine nucleotide exchange factor eIF2B.  This results in reduced 
translation initiation and leaky scanning of ribosomes on mRNAs.
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or its target genes in yeast cells starving for any one of at least six different amino acids 
(21,25).  In addition, motif 2 alterations also significantly reduced binding of uncharged 
tRNA to the HisRS-related domain of GCN2 in vitro (21,26).  The extreme c-terminus of 
Gcn2p is multi-functional, and it has been suggested that its ability to dimerize is central 
to facilitate the HisRS-domain binding to uncharged tRNA (26). Gcn2p binding with 
uncharged tRNA is not restricted to uncharged tRNA
His
; therefore sufficient divergence 
from the bona-fide HisRS enzyme has occurred to allow for binding of many different 
uncharged tRNA species that accumulate during amino acid starvation conditions.  
Furthermore, Gcn2p has reduced affinity for aminoacylated tRNA in vitro, consistent 
with the idea that it is activated by only uncharged tRNA (26). 
Induction of Gcn2p by uncharged tRNA is proposed to involve a transition from 
an inhibited to catalytically active conformation that is signaled by direct contacts 
between the protein kinase domain, HisRS-regulatory region, and the extreme c-terminus 
of Gcn2p (27-28).  Biochemical and genetic studies examining the dynamic interactions 
between the domains of Gcn2p suggest that there is inhibitory contact between the 
protein kinase domain and the Gcn2p c-terminus that is relieved upon binding of 
uncharged tRNA to the HisRS-related domain (26-27,29).  However, release of this 
inhibitory interaction does not appear to be sufficient for induced eIF2 kinase activity.  
Association of uncharged tRNA with Gcn2p is also thought to contribute to a positive-
acting contact between the amino terminal portion of the HisRS-region and the protein 
kinase domain (27,29) (Fig. 3).  Interaction between the HisRS and protein kinase regions 
is proposed to realign kinase subdomains V and VIb, including residues Arg794 and 
Phe842, opening the substrate binding cleft of the catalytic domain and allowing for eIF2 
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binding and phosphorylation.  Located amino-terminal to the Gcn2p catalytic domain is a 
second region sharing homology with protein kinases (Fig. 1).  This so-called partial or 
pseudo-kinase domain is required for induction of eIF2  phosphorylation in response to 
amino acid limitation.  Supporting the model that release of the autoinhibitory interaction 
between the protein kinase and extreme c-terminal regions of Gcn2p is not sufficient for 
activation is the apparent lack of eIF2 kinase activity of the Gcn2p kinase domain by 
itself.  However, this isolated Gcn2p kinase domain becomes hyperactive after residue 
substitutions in the key subdomains V and VIb of Gcn2p (R794G and F842L, designated 
Gcn2p-Hyper) that are proposed to direct an active conformation independent of 
interaction with the HisRS-related or partial kinase regions (29).  More recent evidence 
suggests that a network of hydrophobic interactions centered on Leu-856 results in 
autoinhibition by constraining the critical alpha C helix in the kinase domain which is 
subsequently released by tRNA binding and autophosphorylation of Thr-882 in the 
activation loop (30). 
Accompanying this activated conformation of Gcn2p is autophosphorylation at 
threonine residues 882 and 887 in the so-called activation loop (T-loop) in subdomain 
VII of the kinase domain (31).  This autophosphorylation may occur in trans between 
Gcn2p dimers.  Dimerization of Gcn2p appears to occur independent of amino acid 
starvation, and involves predominantly the extreme c-terminus of Gcn2p, as well as 
weaker contributions between the HisRS-related and protein kinase domains (Fig. 3).  
Upon self phosphorylation, Gcn2p is presumed to retain its induced eIF2 kinase activity 
until it is dephosphorylated by protein phosphatases.  Dephosphorylation of eIF2α is 
thought to be mediated by a type I protein phosphatase encoded by GLC7 (32).  The 
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activity of the Glc7p is regulated by multiple regulatory proteins that associate with this 
phosphatase, enhancing its recognition for phosphorylated protein substrates.  In 
mammalian cells, this process is carried out by the regulatory protein Gadd34, which 
itself is induced in response to eIF2  phosphorylation, as part of a feedback mechanism 
controlling stress gene expression (33-35).  It remains to be determined whether a 
Gadd34 orthologue functions in the regulation of eIF2  phosphorylation and GCN4 
expression in fungi. 
There have also been reported examples of stress induction of GCN4 expression 
independent of Gcn2p.  Induction of Ras2p which leads to activation of protein kinase A 
in yeast is suggested to increase Gcn4p synthesis (36).  Furthermore, defects in tRNA 
processing or nuclear transport enhance GCN4 translation independent of eIF2 
phosphorylation (37-38).  As will be described in the results section, a substantial 
induction of GCN4-lacZ reporter gene activity is observed in gcn2Δ cells grown in media 
containing an alternative nitrogen source.  The mechanistic details of this Gcn2p-
independent induction of GCN4 expression is not known, but it may involve direct or 
indirect reduction in eIF2 activity.  However, this thesis will show that the GAAC is not 
only essential to regulating the transcriptome in response to nutrient deprivation, but also 
for directing gene expression by shifting to alternative nitrogen sources in the growth 
medium. 
 
IV. Ribosome association contributes to Gcn2p protein kinase function 
Targeting of Gcn2p to the ribosomal machinery contributes to the mechanism by 
which Gcn2p monitors the levels of uncharged tRNA in cells.  Association with 
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ribosomes occurs through the extreme c-terminus of Gcn2p (39-40).  A second interface 
between ribosomes and Gcn2p involves the N-terminal of Gcn2p from residues 1 to 272 
(41-43).  This region interacts with a protein complex consisting of Gcn1p and Gcn20p, a 
complex which is also is associated with ribosomes (41,44). 
Several models have been proposed to explain how ribosomal binding can 
contribute to activation of Gcn2p protein kinase in response to starvation for amino acids.  
First, ribosome targeting may facilitate Gcn2p access to its substrate eIF2.  Arguing 
against this idea is the observation that the hyper-activated kinase domain of Gcn2p itself 
efficiently phosphorylates eIF2 in vivo despite the absence of ribosome association (29).  
Furthermore, as discussed further below, the gcn2p-605 mutant which fails to associate 
with ribosomes induces eIF2  phosphorylation and GCN4 translation in response to 
glucose deprivation (45).  Consequently, ribosome association of Gcn2p is not absolutely 
obligatory for eIF2 access in vivo. 
A second model has been proposed that describes a role for ribosome targeting by 
Gcn2p activity involves its requirement for dimerization and trans-phosphorylation.  
Ribosome targeting could elevate localized concentrations of the eIF2 kinase 
polypeptide, thus enhancing the proximity of the Gcn2p that would accentuate the 
formation of dimers.  Dimer formation would then facilitate trans-autophosphorylation at 
the activation loop of the eIF2 kinase domain.  Such a model has been proposed for the 
related eIF2 kinase PKR that participates in an anti-viral defense pathway in mammalian 
cells (46).  Opposing this model is the observation that the dimerization of Gcn2p 
through it c-terminus is quite stable independent of amino acid availability (15).  
12 
 
Therefore, a role for a dynamic equilibrium between Gcn2p monomers and dimers in the 
mechanism of eIF2 kinase regulation appears unlikely.   
A third model for ribosome targeting of Gcn2p that emphasizes the interaction 
between this eIF2 kinase and the Gcn1p-Gcn20p complex revolves around the idea that 
levels of uncharged tRNA are best measured in the context of the ribosome itself.  Gcn1p 
is proposed to be localized in proximity to the A site of ribosomes, and the role of Gcn1p 
as a positive regulator of the GAAC may reside in its ability to eject uncharged tRNA 
that enters the ribosome during elongation (47).  Such evicted uncharged tRNA would be 
transferred by the Gcn1p-Gcn20p complex to the HisRS-related domain of Gcn2p, 
eliciting the active conformation of this eIF2 kinase. While uncharged tRNAs have been 
shown to bind in a codon-dependent manner to the A site of eukaryotic ribosomes, the 
levels of uncharged tRNA required to facilitate such binding in vivo have not yet been 
resolved (48). The Gcn1p-Gcn20p complex may serve to increase the binding of 
uncharged tRNA to ribosomes.  The amount of Gcn1p is much lower than ribosomes in 
yeast, and therefore only a portion of total ribosomes are associated with Gcn1p.  If 
Gcn1p is overexpressed in yeast, which would facilitate the proposed binding of 
uncharged tRNA to ribosomes, there is enhanced sensitivity to the aminoglycoside 
antibiotic paromomycin, a drug that reduces translation fidelity (47). 
Strongly supporting the model that the Gcn1p-Gcn20p complex is critical for 
optimal activation of Gcn2p eIF2 kinase activity in response to amino acid starvation is 
the observation that deletion of GCN1 blocks eIF2 phosphorylation by Gcn2p and the 
resulting induction of translation of GCN4 mRNA (49). As observed for gcn2 mutants, 
including those removing the c-terminal domain of Gcn2p, deletion of either GCN1 or 
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GCN20 render cells hypersensitive to growth inhibition in response to amino acid 
deprivation (41,49-50).  Additionally, this proposed regulatory linkage between Gcn2p 
and Gcn1p appears to be conserved throughout evolution, as orthologues for both 
proteins are found in a range of organisms, including fungi, Caenorabditis elegans, 
Drosophila melanogaster, Arabidopsis, and mammals.  By contrast, orthologues for the 
transcription activator Gcn4p are restricted to certain fungi, although related basic-zipper 
(bZIP) transcriptional regulators may carry out an analogous function in S. pombe and 
higher eukaryotes.  Finally, studies have identified a protein designated Yih1p (IMPACT 
in mammals) that appears to compete with Gcn2p for the Gcn1p positive regulator (51-
52).  Although the precise biological scheme regulating Yih1p is still not understood, 
these studies suggest that Gcn2p binding with Gcn1p/Gcn20p may be an important 
mechanism regulating the GAAC in response to selected stress arrangements. 
 
V. Phosphorylation of eIF2 induces GCN4 translational control 
Translational control of GCN4 mRNA is the major mechanism directing 
expression of this transcriptional activator in response to nutrient limitation.  GCN4 
translation is enhanced by phosphorylation of eIF2  by Gcn2p.  As noted above, ternary 
complexes consisting of eIF2 bound to GTP and initiator Met-tRNAi
Met
 participate in 
ribosomal selection of the start codon.  During this translation initiation process, GTP 
associated with eIF2 is hydrolyzed to GDP and eIF2 is released from the ribosome.  
Recycling of eIF2-GDP to the GTP-bound active form requires a guanine nucleotide 
exchange factor, eIF2B (Fig. 3).  Gcn2p phosphorylation of eIF2  at Ser51 converts this 
initiation factor from a substrate to an inhibitor of the eIF2B, reducing the levels of eIF2-
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GTP available for translation initiation (17,53-54).  The guanine nucleotide exchange 
factor eIF2B consists of five polypeptide subunits designated eIF2B α-ε that are 
organized into catalytic and regulatory sub-complexes (55).  Guanine nucleotide 
exchange is catalyzed by Gcd6p (ε) with the assistance of Gcd1p ( ).  Phosphorylated 
eIF2 associates tightly to the regulatory sub-complex consisting of Gcn3p (α), Gcd7p (β) 
and Gcd2p (δ), preventing eIF2 association with the catalytic sub-complex and blocking 
GDP-GTP exchange (53,55-56). 
Control of GCN4 translation initiation is mediated by four uORFs located in the 
5'- non-coding portion of the GCN4 mRNA (Fig. 4).  These uORFs, numbered from 1 
through 4, are each only two or three codons in length.  Studies involving analysis of 
different configurations of the 5’-leader of the GCN4 mRNA fused to a lacZ reporter 
gene in yeast, and in vitro measurements of ribosome association at different locations 
along the leader of the GCN4 mRNA, support the following model (17,57).  Translation 
of the GCN4 mRNA begins in a cap-dependent fashion with the scanning ribosome 
initiating at the 5'-proximal uORF1.  Upstream ORF1 serves as a positive-acting element 
in GCN4 translational control by allowing ribosomes. to reinitiate at downstream ORFs.  
The basis for the reinitiation capacity is thought to reside in the termination context; 
sequences 3' to the uORF1 stop codon are proposed to facilitate the retention of the small 
ribosomal subunit with the GCN4 mRNA (58).  Following translation of uORF1, 80S 
ribosomes are proposed to decouple while retaining association with the 40S subunit with 
the termination region of the leader of the GCN4 mRNA.  The small ribosomal subunit 
resumes scanning in a 5' to 3' direction along the leader of the GCN4 mRNA.  When 
eIF2-GTP is plentiful during the nonstarved state, the small ribosomal subunit quickly  
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Figure 4.  Gene-specific translational control of GCN4 mRNA.  Schematic depicting 
the translational regulation of GCN4 mRNA.  The GCN4 mRNA is illustrated by the line, 
with the coding region in the black box and the four uORFs numbered 1 – 4 (open boxes) 
indicated in the 5’-leader of the transcript.  In non-stressed (upper) cells when TC levels 
are high, the 40S ribosomal subunit (depicted in light grey) is retained following 
translation of uORF1 by 80S ribosomes (dark grey) and reinitiates at downstream uORFs 
2 – 4, thus preventing translation of the GCN4 coding region and resulting in reduced 
levels of Gcn4p.  In stressed cells (lower), reduced levels of TCs due to inhibition of 
eIF2B activity by phosphorylated eIF2  allow retained 40S subunits to bypass inhibitory 
uORFs 2 – 4 and allow reinitiation at the GCN4 protein coding region.  This results in 
increased GCN4 translation and elevated levels of GCN4p transcription factor.
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reacquires the eIF2 ternary complex and, coupled with the 60S ribosome, reinitiates 
translation at uORF2, uORF3 or uORF4.  Following translation of one of these three 
upstream ORFs, the ribosome dissociates from the GCN4 mRNA, thus blocking 
expression of the downstream GCN4 coding region. 
During amino acid starvation, when eIF2-GTP levels are reduced, there is a delay 
in reinitiation following translation of uORF1.  The increased time required for 
reacquisition of eIF2-GTP coupled with Met-tRNAi
Met 
allows the 40S ribosomal subunit 
to scan through the negative-acting uORFs 2, 3 and 4.  While scanning in the mRNA 
leader from ORF4 to the initiation codon of the GCN4 coding region, the ribosome 
acquires the eIF2 ternary complex, facilitating translational expression of GCN4. 
With limitation for a single amino acid, such as that observed following the 
addition of 3-aminotriazole (3-AT), an inhibitor of histidine biosynthesis to yeast 
cultures, there is enhanced eIF2  phosphorylation and Gcn4p synthesis accompanied by 
a reduction in both general translation and yeast growth.  However, as judged by 
polysome profiles in sucrose gradient sedimentation experiments, there is not necessarily 
a significant accumulation of free ribosomal subunits.  This suggests that there is not a 
major block in translation initiation due to the levels of Gcn2p phosphorylation of eIF2  
induced by the 3-AT inhibitor (39).  This observation indicates that reduced general 
translation accompanying amino acid limitation can be simply a function of the lowered 
levels of free amino acids, rather than lowered availability of eIF2-GTP required to 
sustain general translation initiation.  Therefore, stimulation of GCN4 translation can 
occur in response to a modest reduction in eIF2-GTP that does impede general translation 
initiation.  Re-initiation of translation that occurs in the GCN4 mRNA leader may be 
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particularly sensitive to lowered levels of eIF2 ternary complex accompanying such 
amino acid limitations. 
Reduced translation initiation can occur when a yeast strain auxotrophic for 
amino acids is shifted from media containing complete amino acids to that deprived of all 
amino acids (59).  Under this severe starvation condition where the strain cannot 
synthesize its full complement of amino acids there appears to be enhanced activation of 
Gcn2p and hyperphosphorylation of eIF2  that would further reduce eIF2-GTP levels 
required to sustain general translation initiation.  Constitutively active mutants of GCN2 
or expression of high levels of mammalian eIF2 kinases PKR or PERK/PEK in yeast also 
lead to hyperphosphorylation of eIF2  and a general reduction in protein synthesis (60-
63).  In these conditions of reduced general translation initiation by Gcn2p 
hyperphosphorylation of eIF2  there is still enhanced translation of GCN4 mRNA, 
although there would be lowered levels of general translation including the synthesis of 
proteins encoded by genes transcriptionally induced by Gcn4p.  Together, these studies 
indicate that a range of eIF2  phosphorylation levels can induce gene-specific 
translation, and this translational control can occur in the absence of a general protein 
synthesis defect.  Only after falling below a certain threshold level of eIF2-GTP is there a 
reduction in general translation. 
Regulation of GCN4 translation by eIF2  phosphorylation is also central to 
general control pathways in other fungi such as Candida albicans and Neurospora crassa 
(64-66).  However in these other fungi, the leader of the mRNAs encoding these Gcn4p 
orthologues have only two upstream ORFs.  The first upstream ORF functions similarly 
to the positive-acting ORF1 in yeast GCN4 mRNA, while the second upstream ORF is 
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the sole inhibitory element, preventing ribosomal reinitiation at the downstream coding 
region during the fed state.  This two upstream ORF configuration has been constructed 
artificially in yeast GCN4 mRNA by deleting ORFs 2 and 3 (17).  The GCN4 mRNA 
leader that retains only upstream ORF1 and ORF4 mediates translational control in 
response to eIF2 phosphorylation, albeit at reduced levels compared to the wild-type 
version of GCN4 mRNA containing the full complement of inhibitory upstream ORFs.  
Translation of the related mammalian bZIP transcription factors ATF4 and ATF5 is also 
regulated by a mechanism involving delayed translation reinitiation and two upstream 
ORFs which is analogous to GCN4 arrangement (67-68). 
 
VI. Multiple regulatory mechanisms control Gcn4p levels in response to 
starvation for amino acids 
While translational control is a major mechanism enhancing Gcn4p levels in 
response to nutrient depletion, regulation of the synthesis and stability of GCN4 mRNA 
and protein turnover also contribute to the overall increase in Gcn4p concentrations.  
Elevated synthesis of GCN4 mRNA in response to amino acid limitation in S. cerevisiae 
is modest, with less than a two-fold increase in GCN4 transcription.  As discussed more 
fully below, other stress conditions can induce GCN4 translation and glucose limitation 
or exposure to the drug rapamycin can coincidently enhance as much as a 2 to 3-fold 
increase in GCN4 transcription.  Furthermore, increased synthesis of mRNA encoding 
Gcn4p orthologues in other fungi, such as Candida albicans, Neurospora crassa and 
Aspergillus nidulans, is a significant contributor to overall expression of this 
transcriptional activator (64-65,69).  For example the GCN4 orthologue in A. nidulans, 
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designated cpcA, has an eight-fold increase in its mRNA levels in response to eight hours 
of exposure to 10 mM 3-AT, compared to only a five-fold increase in the CpcA protein 
levels (69).  An important contributor to this increase in cpcA mRNA is autoregulation, 
whereby CpcA binds to its own gene promoter leading to a further amplification of 
expression.  These studies suggest that enhanced mRNA levels can serve in conjunction 
with elevated translation to regulate the expression of Gcn4p-related transcription factors. 
The fact that the leader of the GCN4 mRNA contains short ORFs that precede the 
GCN4 coding region presents challenges to the stability of this mRNA.  Transcripts that 
contain nonsense mutations within the protein coding region are degraded in yeast by the 
nonsense mediated decay (NMD) pathway, preventing the synthesis of truncated proteins 
(70).  The NMD pathway degrades not only nonsense-containing mRNAs, but also those 
with frameshift mutations, improperly-spliced transcripts, and mRNAs containing ORFs 
preceding a coding region.  It is proposed that ribosomes pause at nonsense codons, 
promoting the assembly of a surveillance complex that upon translation termination scans 
towards the 3'-end of the transcript.  An improper translation termination event is 
recognized if the surveillance complex detects a specific downstream sequence element 
(DSE) and associated proteins, leading to assembly of additional factors, including 
Hrp1p, that facilitate decapping of the transcript by Dcp1p.  In the case of the GCN4 
transcript,  there is the presence of a stabilizer element (STE) 3' of uORF4 that associates 
with Pub1p and prevents signaling of the decapping pathway (71).  This would maintain 
stability of GCN4 mRNA independent of the nutritional status of the cell.  However, 
Pub1p binding with RNA does not appear to impede scanning ribosomes, and therefore 
does not prevent translation reinitiation at the GCN4 coding region. 
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Gcn4p resides predominantly in the nucleus where it is highly unstable with a 
half-life of less than 5 minutes (72).  Upon amino acid starvation there is a stabilization 
of Gcn4p that, in combination with increased expression of GCN4, leads to elevated 
steady state levels of Gcn4p and enhanced transcriptional activation.  Degradation of 
Gcn4p depends on its ubiquitination by the ubiquitin-conjugating enzyme Cdc34p in 
combination with the SCF
Cdc4p
 complex (73).  Such ubiquitination directs Gcn4p to the 
proteasome where is it is degraded.  Ubiquitination of Gcn4p is induced by the cyclin-
dependent protein kinase Pho85p that, in conjunction  with its regulatory subunit Pcl5p, 
targets Gcn4p for ubiquitination by specifically phosphorylating Gcn4p at residue Thr165 
(74). Central to the regulation of Pho85p phosphorylation of Gcn4p is the availability of 
Pcl5p.  PCL5 mRNA is induced in response to nutrient limitation by a mechanism 
involving transcriptional activation by Gcn4p.  However, Pcl5p is thought to be labile, 
and it is suggested that translation of PCL5 mRNA is low when there is reduced general 
translation at the onset of an amino acid starvation condition.  Reduced levels Pcl5p 
would lower Pho85p phosphorylation of Gcn4p and insure the availability of this 
transcription factor at the onset of a starvation condition.  With elevated levels of Gcn4p 
and increased expression of its target genes, amino acid levels would be replenished in 
yeast, contributing to increased synthesis of Pcl5p.   
Central to this model is the delayed translation of PCL5 mRNA relative to 
expression of Gcn4p and at least a portion of its target gene products.  This timing of 
stressed-induced gene expression has not yet been well addressed experimentally. A 
second cyclin-dependent protein kinase Srb10p is also linked to Gcn4p turnover, and 
deletion of SRB10 and PHO85 together is required for maximum stability of Gcn4p (75).  
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Srb10p may phosphorylate five distinct residues in Gcn4p, including Thr165.  Similar to 
that described for Pho85p, such Srb10p phosphorylation is thought to mediate 
degradation of Gcn4p through Cdc34p and possibly the SCF
Cdc4p
 complex.  However, 
regulation of Gcn4p levels by Srb10p appears to be controlled independent of the 
availability of amino acids. 
 
VII. Gcn4p interacts with the core transcriptional machinery to coordinate gene 
expression 
Gcn4p is a member of the bZIP family of transcription factors.  The bZIP region 
located at the extreme c-terminus of Gcn4p is important for Gcn4p dimerization and 
binding to GCREs embedded in the promoter regions of target genes (76).  While other 
members of this family such as mammalian ATF4 can heterodimerize with other bZIP 
proteins, Gcn4p is thought to function primarily as a homodimer (77).  Such DNA 
binding can occur in the absence of nutrient limitation, contributing to the basal 
expression of Gcn4p regulated genes.  This is best illustrated by the observation that 
while yeast cells deleted for GCN4 are viable they can no longer grow without all amino 
acids supplemented in the growth medium.  With the increased levels of Gcn4p that are 
observed during amino acid starvation, there is enhanced Gcn4p binding to GCREs and 
stimulation of transcription.  Early studies on the transcriptional target genes of Gcn4p 
focused on amino acid biosynthetic genes (76).  These have been expanded by microarray 
studies in cells starved for branched-chain amino acids (78) or histidine (79).  The latter 
study will be described in much more detail below.  Activation of transcription involves 
the amino-terminus of Gcn4p which contains seven clusters of hydrophobic residues 
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interspersed among acidic residues (80).  These hydrophobic segments are essential for 
recruitment of multi-subunit protein complexes, collectively referred to as coactivators 
(81-82). 
Genetic analysis of the viable mutants generated by the Saccharomyces Genome 
Deletion project indicates that at least seven different coactivator complexes can 
associate with Gcn4p and impact expression of genes subject to GAAC (82). One of the 
best characterized examples of Gcn4p-coactivator interaction involves the SAGA 
complex, which contains the histone acetyltransferase (HAT) subunit, Gcn5p (83).  
Acetylation of nucleosomal H3 and H2B by Gcn5p leads to remodeling of chromatin that 
exposes or masks binding sites for TATA-binding protein (TBP) and RNA polymerase II 
in core promoter regions.  Along with Gcn5p, SAGA contains TBP-associated factors 
(TAFs) that directly contribute to recruitment of general transcription factors.  Additional 
Gcn4p co-activator complexes are SWI/SNF and RSC that hydrolyze ATP to displace 
nucleosomes and alter the availability of protein binding sites in promoters (82,84). 
The precise contribution of these coactivators in Gcn4p-mediated induction of 
transcription is still not completely understood.  Clearly, portions of different coactivator 
complexes can contribute to activation by Gcn4p at individual target gene promoters.  For 
example, mutations in multiple subunits of seven different coactivators, including SAGA, 
SWI/SNF, and RSC, lowered the induced levels of HIS4 and SNZ1 mRNA in response to 
amino acid limitation compared to transcription in wild-type cells (82).  Surprisingly, 
among the SAGA subunits characterized, only Gcn5p was dispensable for increased 
expression of these Gcn4p target genes in response to amino acid starvation.  By 
comparison, significant induction of ARG1 expression required four coactivators, RSC, 
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CCR4/NOT, SRB/MED and PAF1 complex (THO/TREX), with SAGA and SWI/SNF 
being dispensable (82).  However, ChIP experiments measuring recruitment of Gcn4p-
associated proteins to the chromatin of the ARG1 promoter region indicated that SAGA 
and SWI/SNF1, in addition to SRB/MED, were strongly associated in response to amino 
acid starvation conditions.  Less pronounced, albeit significant, Gcn4p-dependent 
immunoprecipitation in the ARG1 promoter region was observed for coactivators 
SRB/MED and PAF1 complex.  These results suggest that Gcn4p can recruit more 
coactivators to a given target promoter than is required for full expression in response to 
nutrient deprivation (82).  Given that Gcn4p activates hundreds of genes, Gcn4p may 
interact with many different coactivators to overcome diverse regulatory arrangements in 
target promoters.  It is unlikely that these large multi-subunit coactivator complexes 
reside at a given promoter simultaneously.  Perhaps each coactivator binds transiently, 
contributing their specific functions at the promoter and dissociating prior to entry of a 
different coactivator complex.  Furthermore, the subunit composition of coactivator 
complexes may vary between different promoter contexts, with certain subunits being 
dispensable for coactivator complex function or combining differentially to form diverse 
complex arrangements. 
While GCREs are an important feature of Gcn4p-mediated activation of gene 
transcription, almost half of the genes which were shown to be induced by four-fold or 
more following treatment with 3-AT and dependent on Gcn4p function had no 
recognizable binding element in their promoter region or sequences upstream of their 
translation start site (20,79).  It is certainly possible that these genes have GCREs in the 
transcribed portion of the gene (intron or exon regions) which have functional 
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significance for transcriptional induction.  An alternative explanation is that 
transcriptional control of these genes by Gcn4p is indirect.  As described below, Gcn4p 
induces the expression of a large collection of transcriptional activators.  Furthermore, 
Gcn4p could modulate transcription through protein-protein interactions that are 
independent of GCRE binding at a regulated gene.  For example, Gcn4p could bind and 
inactivate transcriptional factors that mediate repression of genes void of GCREs. 
While Gcn4p is predominantly viewed as an activator of transcription, DNA 
microarray analysis of Gcn4p-dependent gene expression in 3-AT treated cells has 
suggested that Gcn4p can also contribute to repression of transcription (79).  For example 
as studied further in this thesis, there is a dependence on Gcn4p for repressed 
transcription of genes encoding ribosomal proteins or translation factors in response to 
amino acid starvation conditions.  Since not all of these genes have recognizable GCREs 
in their promoter regions, it was speculated that Gcn4p probably contributes indirectly to 
their repressed expression.  This is further supported by the observation that 
overexpression of Gcn4p in the absence of nutrient limitation also reduces transcription 
of ribosomal protein genes (85).  Collectively, expression of these genes are reduced 
during amino acid starvation conditions by mechanisms involving the transcriptional 
regulator Rap1p and signal pathways controlled by protein kinase A and Tor proteins 
(84,86-90).  It is proposed that elevated levels of Gcn4p may enhance transcriptional 
repression in concert with these regulatory pathways by Gcn4p binding and sequestering 
transcription factors required for expression of ribosomal proteins and translation factors 
(79).  Gcn4p is also reported to enhance expression of protein kinases and phosphatases, 
providing for a range of possible mechanisms that could modulate these signaling 
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pathways.  Finally, Gcn4p is linked to expression of a large number of other transcription 
factors that together could combine for direct and indirect Gcn4p control of diverse stress 
pathways.  One such factor, Uga3p, a zinc-finger containing transcription factor required 
to induce expression of genes involved in the catabolism of GABA as a secondary 
nitrogen source, is a central focus of experiments in this thesis. 
 Gcn4p has been termed the “master regulator” of a five layered program of gene 
regulation designed to alleviate nutrient deprivation (20,79).  Certainly, the core layer of 
Gcn4p transcriptional control involves genes directly contributing to the synthesis of 
amino acids, a group of target genes that had been widely studied previously (76).  As 
noted above, general control is a true cross-pathway stress response in that starvation for 
a single amino acid, such as histidine, induces the expression of genes directly involved 
in the synthesis of all 20 amino acids.  It has been confirmed for a large number of these 
amino acid biosynthetic genes that their encoded enzyme activities are induced as part of 
the general control program.  Natarajan et al. (79) reported that of the 539 genes whose 
transcription requires Gcn4p for full induction in response to amino acid depletion, only 
73 contribute to amino acid biosynthesis.  Therefore, the influence of Gcn4p exceeds 
beyond core amino acid synthetic genes, a key point that will be emphasized in latter 
sections of this dissertation. 
The second layer of gene regulation by Gcn4p involves intermediary metabolism 
related to amino acid biosynthesis and nutrition (79).  For example, it was reported that 
following 3-AT treatment, 16 genes were induced that function in the synthesis of 
vitamins that are important cofactors for enzymes in pathways related to amino acids.  
Expression of several genes encoding amino acid permeases are induced by Gcn4p 
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following amino acid starvation, including the mRNA for the general amino acid 
permease Gap1p, a protein critical to nitrogen regulation in yeast.  In addition, mRNAs 
for the basic amino acid permease Can1p, and a broad spectrum permease Agp1p were 
also induced.  Of the 35 members of the mitochondrial carrier family involved in 
metabolite transport between this organelle and the cytoplasm, 10 are regulated 
transcriptionally by Gcn4p.  Given that portions of the synthetic pathways for arginine, 
lysine and the branched chain amino acids are carried out in the mitochondria, it is 
rationalized that the availability of such transport systems is linked to the demands of the 
amino acid biosynthetic pathways.  Another organelle associated with Gcn4p-directed 
gene expression is the peroxisome.  The peroxisome has a primary role in the β-oxidation 
of fatty acids and detoxification which may be linked with a yeast cell strategy for coping 
with amino acid depletion.  With regards to amino acid biosynthesis, lysine synthetic 
enzymes Lys1p and Lys4p are located in the peroxisome, and certain peroxisomal 
mutants in Pex8p and Pex15p are impaired for synthesis of lysine (91).  Therefore, 
Gcn4p-directed expression of peroxisomal-related genes may contribute to enhanced 
lysine production. 
It is of interest to note that Gcn4p also induces five purine biosynthetic genes in 
response to amino acid limitation, and as further discussed below purine deprivation is a 
potent inducer of eIF2 phosphorylation and GCN4 translational control (79,92).  The 
physiological basis for this regulatory linkage may involve the metabolic overlap 
between the biosynthesis of certain amino acids and purines.  For example, the purine 
ring of ATP is utilized early in the histidine biosynthetic pathway, and induced purine 
synthesis by Gcn4p may be important for supporting enhanced histidine production.  The 
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connection between histidine and purine synthesis is also highlighted by the regulation 
and function of HIS7 encoding glutamine amidotransferase cyclase (93).  This 
bifunctional enzyme catalyzes the fifth and sixth step in the histidine synthetic pathway 
and produces the by-product 5-aminoimidazole-4-carboxamide ribotide (AICAR) which 
is an important intermediate in the purine pathway.  Regulation of HIS7 involves Gcn4p 
binding to two GCREs, designated 1 and 2, in its promoter region that work 
synergistically to induce transcription.  In response to adenine limitation, a second 
transcriptional activator Bas1p in complex with Bas2p is thought to bind GCRE-2 and 
activate HIS7.  Both Gcn4p and the Bas1p/Bas2p complex are required for maximal 
expression of HIS7 in response to combined starvation for amino acids and purines.  
BAS1, which functions to activate the transcription of multiple purine biosynthetic genes, 
is itself transcriptionally regulated by Gcn4p (79).  Therefore, Gcn4p contributes to 
increased expression of HIS7 both directly and through enhanced expression of other 
stress-related transcription factors.  
The third layer of the Gcn4p-mediated program of gene regulation involves 
control of the translational machinery.  As highlighted above, Gcn4p is required for 
reduced expression of a number of translation factors and some 90 ribosomal protein 
genes (79).  Such a reduction in the synthesis of the translational machinery would be 
appropriate with the reduced cellular growth rates associated with lowered amino acid 
availability.  This regulatory strategy is analogous to the well described stringent 
response in Escherichia coli that represses synthesis of rRNA and subsequently 
ribosomal proteins in response to amino acid starvation (94).  It is interesting to note that 
in both E. coli and yeast, the signal for this repression is proposed to be placement of 
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uncharged tRNA into the A sites of ribosomes.  By contrast, Gcn4p enhances the 
expression of a number of different aminoacyl-tRNA synthetases genes following 3-AT 
treatment, including KRS1, ILS1 and MES1, suggesting a mechanism to enhance the 
efficiency of aminoacylation of their corresponding cognate tRNAs during conditions of 
reduced amino acids (79).  Interestingly, as described earlier, RM-A, an inhibitor of 
isoleucyl-tRNA synthetase induces ILS1 mRNA diminishing growth inhibition by this 
compound (95).  However, aminoacyl-tRNA synthetases are not uniformly induced by 
histidine limitation.  In fact, genes encoding GlnRS, PheRS, and SerRS are repressed in 
cells exposed to 3-AT.  Therefore, the role of Gcn4p and its impact on aminoacylation of 
different tRNA species has yet to be resolved. 
A fourth layer of Gcn4p-mediated control involves broader themes in cellular 
stress responses.  Starvation for various nutrients, including limiting nitrogen or 
carbohydrates, induces a process of autophagy that facilitates the bulk turnover of 
cytoplasmic material.  Autophagosomes, which have many parallels to lysosomes in 
higher eukaryotes, deliver cytoplasmic proteins and organelles to yeast vacuoles, where 
they are degraded and reclaimed for later use (96).  Gcn4p induces the expression of two 
vacuolar proteases and three autophagy proteins, including the protein kinase Apg1 and 
its associated protein Apg13 that are instrumental for activating the autophagy process 
(79).  The absolute requirement of GCN4 for autophagy remains controversial.  In 
response to histidine starvation, autophagy was reported to occur independent of Gcn4p 
function (79).  By contrast, Talloczy et al. (97) suggested that autophagy in response to 
nitrogen starvation is blocked in yeast strains devoid of GCN4 or GCN2.  The apparent 
conflict between the two studies may lie in the different yeast strains utilized or in the 
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different nutrient stresses used to invoke autophagy.  It has been observed that nitrogen 
limitation is a potent inducer of autophagy, while starvation for an amino acids such as 
tryptophan leads to accumulation of fewer autophagic bodies (98).  A further 
complication is that while nitrogen starvation induces eIF2 phosphorylation by Gcn2p, 
reportedly there is no synthesis of Gcn4p (99).  The mechanistic basis for the absence of 
Gcn4p expression during nitrogen deprivation is not understood, but it is reasoned that 
complete starvation for nitrogen would thwart amino acid biosynthesis. 
General nutrient starvation also leads to accumulation of glycogen.  This polymer 
of glucose begins to accumulate as nutrients begin to be depleted, allowing yeast cells to 
accumulate carbohydrates to be utilized upon resumption of vegetative growth or during 
spore germination (100).  Gcn4p contributes to the expression of several proteins 
involved in glycogen accumulation, including glycogen synthase, glycogenin and the 
branching enzyme (79).  Glycogen synthesis and turnover varies considerably during the 
time course of a nutrient-depletion study.  Utilizing matched yeast cultures shifted from 
synthetic medium containing 2% to 0.05% glucose, a condition that induces eIF2 
phosphorylation by Gcn2p and GCN4 translation, it was found that there was a 7-fold 
increase in glycogen levels after two hours of culture incubation (45).  Accumulation of 
glycogen was similar between strains containing wild-type or deleted GCN2 function.  
However, following 22 hours of incubation in the glucose-deficient media, glycogen 
levels were more significantly reduced in the absence of Gcn2p activity, with the gcn2 
mutant cells having four-fold less glycogen than the wild-type strain.  Therefore, the 
general control has important roles in both amino acid and carbohydrate metabolism. 
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The fifth and final layer of Gcn4p-directed gene expression involves the induction 
of signaling proteins such as protein kinases, protein phosphatase catalytic and regulatory 
subunits, and transcription factors.  Activation of these regulatory genes may allow for 
amplification of the general control response, and provide for a means of communication 
with other stress response pathways.  In the case of protein kinases, it was noted above 
that Gcn4p induces expression of Apg1 protein kinase which is important for eliciting 
autophagy (79).  Autophagy is also positively regulated by Snf1p protein kinase, required 
for glucose derepression, and negatively impacted by nutrient sensing protein kinases Tor 
and Pho85p (96).  Therefore, multiple nutrient stress response pathways interconnect to 
control this catabolic trafficking process.  Another protein kinase whose expression is 
induced by Gcn4p is Npr1p.  Npr1p promotes the stabilization Gap1p, a general amino 
acid permease, and the proteolysis of the tryptophan permease Tat2p (89).  As described 
above Gcn4p activates GAP1 expression, and the added NPR1 expression may further 
contribute to the cellular uptake of amino acids.  Npr1p is also inhibited by Tor-directed 
protein phosphorylation, further emphasizing cross pathway control of key nutrient 
regulatory steps.  In the example of phosphatase-related genes, Gcn4p directs expression 
of Gip1p, a Type 1 protein phosphatase interacting protein required for synthesis of spore 
walls (79).  Sporulation in yeast occurs in response to starvation for nitrogen in the 
absence of a fermentable carbon source, and the linkage between Gcn4p and spore wall 
formation may suggest that Gcn4p can contribute to a range of stress response options in 
yeast. 
Gcn4p enhances expression of 26 different transcription factors involves in a 
broad range of stress response.  The largest collection of transcription factors are 
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involved in amino acid and purine biosynthesis, including Arg80p, Bas1p, Gln3p, Leu3p, 
Lys14p, Met4p, and Met28p (79).  This suggests that the general control pathway can be 
fine tuned to accommodate transient cellular requirements for individual amino acids.  As 
noted above Bas1p is critical for expression of purine biosynthetic genes and the histidine 
pathway gene HIS7.  The example of Leu3p nicely illustrates this idea of superimposition 
of pathway specific regulation onto general control.  Leu3p binds to promoter elements in 
a large number of genes involved in branched chain amino acid synthesis and represses 
transcription (101).  In the presence of the leucine biosynthetic precursor α-
isopropylmalate (α-IPM), Leu3p becomes an activator of transcription.  Levels of α-IPM 
are subject to the availability of leucine through feedback inhibition of α-IPM synthase, 
the LEU4 product.  Therefore, leucine levels would dictate whether Leu3p functions as 
an activator or repressor.  In response to 3-AT treatment, Gcn4p also induces expression 
of genes encoding transcription factors involved in peroxisome proliferation (PIP2, and 
see discussion in the third layer of Gcn4p-direction gene expression), utilization of poor 
nitrogen sources (GAT1 and UGA3), heat shock (HSF1), maltose catabolism (MAL13), 
and meiosis (RIM101) (79).  Utilization of alternative nitrogen sources is a major theme 
of this thesis.  Overall, this collection of transcription factors may work in concert with 
Gcn4p, insuring that the timing and content of stress gene expression is appropriately 
tailored to a mosaic of stress inputs. 
The multi-layered model of target gene induction described above was developed 
in large part through the use of large scale microarray studies in cells treated with 3-AT 
to elicit starvation for histidine (79).  We propose that the Gcn4p-directed transcriptome 
may be differentially modulated during different nutrient-related stress conditions.  In this 
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way, the resulting gene expression could elicit metabolic patterns that best alleviate the 
specific underlying stress.  To address this idea, in this thesis we compared GAAC-
directed transcription changes during 3AT treatment with inactivation of TORC1 with 
rapamycin or growth in the presence of alternative nitrogen sources. 
 
VIII. The general control pathway and yeast physiological strategies 
Yeast can synthesize each of its twenty amino acids de novo.  However, in rich 
medium replete with amino acids, yeast import amino acids and reduce the levels of 
Gcn4p-directed gene expression.  This insures that yeast do not synthesize biosynthetic 
enzymes unnecessarily, and facilitates a rapid doubling time.  When there is an imbalance 
of amino acids in the medium, yeast will enhance biosynthetic genes to generate the 
required metabolites.  In the laboratory, addition of 3-AT or sulfometuron methyl (SM), a 
chemical inhibitor of branched chain amino acid biosynthesis, induces high levels of 
Gcn4p and its target genes (21).  The yeast GAAC induces expression of not only genes 
required for the biosynthesis of the limiting amino acids but also those involved in 
synthesis of non-limiting amino acids.  Much of this analysis has measured transcript 
levels and many of these genes have not yet been assessed for induced protein synthesis.  
Furthermore, given feedback inhibition for many of these biosynthetic pathways, 
expression of these many genes does not necessarily dictate that there is increased flux 
through each pathway.  Nevertheless, it appears that yeast has coupled a central 
mechanism for induction of many biosynthetic pathways to a single signal- accumulation 
of uncharged tRNA.  Zaborske et al. (22) has used a genome-wide analysis of tRNA 
charging to determine that starvation for individual amino acids can lead to elevated 
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levels of deacylated tRNAs representing both the limiting and non-limiting amino acids.  
This suggests that the cross-regulation also extends to the proposed uncharged tRNA 
activating signal. 
Previous studies from this lab suggest that an important goal of the GAAC 
pathway is storage of nitrogen in the form of amino acids in response to severe nutrient 
deprivation (45).  Upon glucose deprivation, yeast enhance their overall levels of free 
amino acids, with an elevation in the vacuolar amino acid pool and a concomitant 
depletion in the cytoplasmic amino acid levels.  Concentrations of individual amino acids 
in the vacuole vary, with glutamate constituting nearly a third of the total pool, and 
arginine and alanine each constituting about 10% (102).  Initially this increase in vacuolar 
amino acid levels is independent of Gcn2p activity (45).  But with longer periods of 
glucose limitation, the levels of vacuolar amino acids are much reduced in GCN2-
deficient cells compared to wild-type.  As noted above, such glucose limitation increases 
eIF2 phosphorylation and GCN4 translational, and these results suggest that induced 
general control contributes to the storage of amino acids when carbohydrates are limiting 
and there is reduced protein synthesis and cell growth.  The storage of amino acids during 
nutrient limitation would provide yeast cells ready access to nitrogen when the 
carbohydrates again become accessible (45).  Importantly, vacuolar storage of amino 
acids is also triggered in response to reduced assimilation of ammonia, indicating that this 
storage strategy is invoked in response to diverse nutrient stress conditions (102). 
Accumulation of glycogen also occurs in yeast when glucose or amino acids 
begin to be depleted in the culture media and yeast cells have reduced their rate of growth 
(100).  As highlighted above, the maintenance of accumulated glycogen levels is 
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dependent on Gcn2p protein kinase activity, suggesting that general control has a broad 
role in storage of nutrients (45).  It is noted that loss of GCN4 is suggested to enhance 
glycogen accumulation as judged by iodine staining of cells grown on synthetic dextrose 
agar medium (79).  This may suggest some differences between GCN2 and GCN4-
deficient strains.  However, the timing in such iodine staining experiments is critical as 
glycogen synthesis and turnover change during growth phases. GCN4-deficient strains 
have a clear requirement for amino acid supplements for robust growth, and the absence 
of this transcription factor could enhance nutrient starvation signals that trigger early 
activation of glycogen synthase.  This in turn would lead to earlier glycogen 
accumulation in gcn4 mutant strains compared to wild-type cells.  Similarly, vacuolar 
amino acid levels are enhanced in gcn4 mutant cells grown to mid-logarithmic phase in 
synthetic medium in the absence of amino acid supplements as compared to wild-type 
strains (45).  With the addition of all twenty amino acids to the medium, there is a 
reduction in the vacuolar amino acid pool in the gcn4 mutant, albeit the amino acid levels 
still remain significantly higher than that measured in non-starved wild-type cells.  
Therefore, the loss of GCN4 function is itself a stress that can trigger certain coping 
strategies.  By comparison, GCN2-deficient cells, which retain some basal expression of 
Gcn4p, are not amino acid auxotrophs and can provide an important alternative tool to 
assess the contribution of the induced general control response to stress conditions. 
Gcn4p orthologues are also required for longer term strategies for dealing with 
nutritional stress in other fungi.  For example in the dimorphic fungi Candida albicans, 
Gcn4p facilitates filamentous growth in response to amino acid starvation.  Such 
filaments enable this fungi to  forage for new resources when nutrients are depleted (64).  
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In Aspergillus nidulans, the related Gcn4p transcription factor CpcAp functions in a cross 
pathway control, and serves to block formation of cleistothecia or fruit bodies when 
nutrients are limiting (103).  Formation of these complex reproductive structures 
consumes macromolecules and energy, and induced CpcAp expression would signal that 
inadequate nutrients are present to carry out this process. 
 
IX. Multiple stresses activate Gcn2p eIF2 kinase activity 
Phosphorylation of eIF2 by Gcn2p occurs in response to diverse nutrient 
limitations, including starvation for different amino acids, purines, or glucose. 
Accumulation of uncharged tRNA is thought to be the activating signal for each of these 
starvation condition because yeast expressing gcn2-m2, defective for binding to 
uncharged tRNA, are unable to induce eIF2α phosphorylation and mediate GCN4 
translation control.  Purine starvation may elicit elevated uncharged tRNA levels by 
reducing ATP levels or the biosynthesis of certain amino acids, such as histidine, or by 
altering the processing of tRNA.  In the case of glucose limitation, accompanying energy 
reductions or the lowering of amino acid levels in the cytoplasm that accompany vacuole 
accumulation of amino acids could lead increased uncharged tRNA.  While 60S 
ribosomal association is thought to be obligate for activation of wild-type Gcn2p during 
amino acid limitation, it appears to be largely dispensable in response to glucose 
limitation (45).  Furthermore, the requirement for Gcn20p is not essential for induced 
GCN4 expression during this deprivation for this carbohydrate.  These results suggest 
that uncharged tRNA is an important signaling molecule that activates Gcn2p in response 
to many different nutritional limitations.  However, there may be differences between the 
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mechanisms by which uncharged tRNA is delivered to and recognized by Gcn2p during 
amino acid and carbohydrate deficiency.   
In addition to nutrient limitation, many other stress conditions have been recently 
reported to activate Gcn2p eIF2 kinase activity.  Exposure of yeast cells to high 
concentrations of sodium, volatile anesthetics, the immunosuppressant rapamycin, methyl 
methanesulfonate (MMS), or tunicamycin have been reported to induce eIF2 
phosphorylation, and many of these conditions have also been shown to elevate GCN4 
translation (14,16,79,104-105).  Two fundamental questions come to mind concerning the 
induction of eIF2 phosphorylation by these diverse stress conditions.  First, what are the 
mechanisms activating Gcn2p in response to these diverse stresses?  And second what is 
the physiological rationale for inducing Gcn4p in response to this range of cellular stress 
conditions.  We still do not yet have clear answers to these questions, although there are 
several clues that provide insight into likely explanations.  These clues and insights are 
provided below. 
The first question concerns the signals that activate Gcn2p in response to this 
diverse collection of stress conditions.  In the examples of sodium toxicity, anesthetics 
and rapamycin there is a linkage to amino acid metabolism.  Exposure to anesthetics and 
elevated concentrations of sodium are suggested to impair uptake of amino acids by yeast 
(104-105).  Uptake of leucine or tryptophan is inhibited by anesthetics, and the enhanced 
levels of these amino acids to the medium can overcome the growth defect associated 
with anesthetics.  Furthermore, yeast cells prototrophic for amino acid biosynthesis are 
resistant to anesthesia.  Together these observations support the idea that the 
physiological action of anesthesia involves amino acid uptake in cells and nutrition 
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availability.  Along similar lines, the immunosuppressant Tacrolimus (FK506) functions 
independently of calcineurin to block tryptophan uptake resulting in Gcn2p activation 
(106).  An inihibitor of isoleucyl-tRNA synthetase, Reveromycin A (RM-A), activates 
Gcn2p kinase activity and GCN4 translation (95).  The example of activation of Gcn2p 
by high levels of sodium is complex.  While elevated concentrations of either sodium or 
potassium reduce yeast uptake of phenylalanine and leucine, only sodium induces eIF2 
phosphorylation and GCN4 translational control (104).  Furthermore, general control in 
yeast strains prototrophic for amino acids is still activated by the addition of high sodium 
concentrations to the medium (15).  These results suggest that sodium stress is induced 
by a mechanism other than nutritional starvation due to reduced uptake of amino acids.  
The identity of one or more of these alternative sodium stress signals is currently not 
known.  However, it was recently reported that elevated levels of sodium enhanced the 
levels of uncharged tRNAs for selected amino acids, supporting the idea uncharged 
tRNA binding is at least one reason for activation of Gcn2p during this stress conditions 
(22).  A curious note regarding sodium stress is that deletion of GCN2, or other general 
control genes such as GCN1, confer growth resistance to sodium (104).  Such sensitivity 
may indicate that sodium induces hyperphosphorylation of eIF2 and a block in 
translation. By deleting the eIF2 kinase, protein synthesis would not be impeded by 
sodium stress.  By contrast, deletion of GCN4 is reported to confer growth sensitivity to 
sodium (104).  Gcn4p activates transcription of HAL1, an important regulator of salt 
balance, through antagonism of Sko1p repressor.  The apparent phenotypic difference 
whereby gcn2 mutant cells are growth resistant, and gcn4 mutant cells are sensitive has 
also been reported for rapamycin treatment (14). 
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As will be discussed further below, Tor has a central role in linking protein 
synthesis and cell growth and division to nutrient sufficiency, and rapamycin complexes 
with the immunophilin-related protein Fpr1 to inhibit this protein kinase in yeast 
(89,107).  Interestingly, rapamycin stimulates eIF2 phosphorylation by Gcn2p in non-
starved cells by blocking Tor-mediated phosphorylation of Gcn2p at serine-577, located 
upstream of the kinase domain (14).  Tor phosphorylation of Gcn2p is not thought to be 
direct, but rather through an unknown protein kinase that is downstream of Tor and 
Tap42p-regulated type 2A and type-2A-related protein phosphatatases.  Phosphorylation 
of Gcn2p at serine-577 reduces its binding to uncharged tRNA, while an alanine 
substitution at serine-577 contributes to induced Gcn2p eIF2 kinase activity independent 
of nutrient availability.  Induction of Gcn4p increases expression of amino acid 
biosynthetic genes, and contributes in concert with Tor to activation of genes required for 
catabolism of poor nitrogen sources, as well as repression of genes encoding ribosomal 
proteins and translation factors.  Thus, rapamycin-mediates dephosphorylation and 
activation of Gcn2p, and this linkage between the Tor and Gcn2p provides a mechanism 
of cross-talk between different nutrient sensing pathways, the latter point being addressed 
by experiments in this dissertation.  It is noteworthy that the nutritional stresses 
characterized, amino acid or purine starvation, do not contribute to dephosphorylation of 
Gcn2p at serine-577 (14); therefore, the precise nutritional stress modulating Tor-directed 
control of general control remain to be determined.  Uncharged tRNA may be a 
contributing signal to activation of Gcn2p by rapamycin, given that yeast containing 
gcn2-m2 are blocked for induction of GCN4 translation in response to rapamycin 
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exposure.  However, there is currently no evidence to support the idea that rapamycin 
treatment alters the efficiency of aminoacylation of tRNA. 
The final examples of stress agents which activate Gcn2p that will be discussed 
are MMS and tunicamycin.  MMS induces DNA damage, and DNA microarray analysis 
indicates that this alkylating agent induces expression of genes involved in synthesis and 
repair of DNA and detoxification, and represses those functioning in the synthesis of 
nucleotides, RNA and ribosomes (108).  Interestingly, over 90 genes involved in amino 
acid biosynthesis are induced by twofold or more, suggesting a linkage between MMS 
and the general control pathway.  Indeed, MMS enhances eIF2  phosphorylation by 
Gcn2p and GCN4 translation (79).  This induction mechanism is blocked in yeast 
containing the gcn2-m2 mutation or defects in GCN1 or GCN20, supporting the model 
that uncharged tRNA is a contributing signal to activation of Gcn2p in response to MMS.  
Furthermore, mutations in checkpoint proteins that are required for response to DNA 
damage, e.g. Rap53p, do not reduce MMS induction of GCN4 expression (79).  This 
suggests that important signaling pathway required for repair of DNA damage are not 
involved in activation of Gcn2p.  
Proteins are substrates for MMS alkylation which can lead to impaired activity of 
enzymes, such as aminoacyl-tRNA synthetases.  However to our knowledge, there have 
not been any reports of increased uncharged tRNA levels in yeast treated with MMS.  It 
is also noted that oxidized proteins are ubiquitinated and degraded in proteasomes, and 
impaired proteasome function in mammalian cells through drug treatment or by 
overexpression of proteins containing poly-glutamine sequences can lead to ER stress 
linked to the eIF2 kinase PERK/PEK (109).  One mechanism by which the ER secretory 
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pathway manages misfolded protein in the ER lumen is to evict such proteins back to the 
cytoplasm for ubiquitin-mediated degradation.  Proteasome dysfunction in the cytoplasm 
would block such protein degradation, contributing to a backup of misfolded protein in 
the ER lumen that elicits an ER stress response.  Perhaps, MMS-damaged proteins in 
yeast also overload the proteasome, contributing to not only a cytoplasmic stress but also 
stress in the ER.  In the case of the ER transmembrane protein PERK/PEK, the ER 
chaperone GRP78 binds to the lumenal portion of PERK/PEK and represses its 
cytoplasmic eIF2 kinase activity (110-111).  Misfolded protein in the lumen of the ER is 
proposed to titrate GRP78 from PERK/PEK, facilitating oligomerization and trans 
phosphorylation that induces eIF2 kinase activity.  The cytoplasmic chaperone Hsp90p 
binds yeast Gcn2p and is proposed to have a critical role for Gcn2p maturation and 
regulation (112).  Following the model proposed for PERK/PEK and ER stress, perhaps 
Hsp90p inhibition of Gcn2p is relieved by accumulation of damaged protein that 
selectively titrates the cytoplasmic chaperone from mature Gcn2p.  Removal of Hsp90 
from Gcn2p may contribute to an activated conformation and elevated eIF2 kinase 
activity.  Altered proteasome function has also been proposed to alter efficient turnover 
of proteins that could modify Gcn4p activity or expression (113). 
Tunicamycin blocks protein glycosylation in the ER and contributes to misfolded 
protein in this organelle (114-115).  Unlike mammals, S. cerevisae has only a single eIF2 
kinase Gcn2p.  However, yeast does have Ire1p, a transmembrane ER protein kinase that 
shares sequence similarities with mammalian PERK/PEK in its ER lumenal regions 
(116).  Ire1p activates the expression of Hac1p, a transcriptional activator of genes 
important for ER protein folding and secretion.  In mammals, PERK/PEK 
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phosphorylation of eIF2 serves to reduce general translation, preventing further synthesis 
of secretory proteins that would further overload the ER.  Additionally, PERK/PEK 
induces expression of the transcriptional activator Atf4 and its target genes in mammalian 
cells subjected to ER stress (67).  Given that PERK/PEK is not present in yeast it was 
assumed that this portion of the ER stress pathway was absent from fungi.  However with 
the observation that tunicamycin can activate Gcn2p eIF2 kinase activity, it is inviting to 
speculate that Gcn2p has assumed a translational regulation role during ER stress (79).  
Glucose deprivation in mammals also induces ER stress and PERK/PEK activity (114-
115).  Therefore, the observation discussed above that glucose deprivation can induce 
eIF2 phosphorylation in yeast may further support this ER stress linkage with Gcn2p.  It 
is curious that a DNA microarray study measuring tunicamycin-induced gene expression 
in yeast did not identify Gcn4p-directed amino acid biosynthetic genes (117).  This may 
indicate that during ER stress, Gcn2p functions predominantly to regulate general 
translation, and there is a decoupling of GCN4 expression.  Genetic variations between 
yeast strains could also impact the different contributions of the general control on ER 
stress responses. 
 
X. Integration of the general control pathway and TOR signaling in nitrogen 
assimilation in yeast 
As noted above, another stress response pathway that is important for monitoring 
nutrient availability involves the target-of-rapamycin (TOR) signaling pathway (118).  In 
its natural environment, yeasts are subjected to wide fluctuations in nutrients and the 
TOR signaling pathway is a central mechanism by which cellular metabolism and growth 
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is coordinated with environmental cues (119).  TOR is a large serine/threonine protein 
kinase belonging to the phosphatidylinositol kinase-related kinase (PIKK) family (120) 
and as a critical regulator of cell growth that regulates multiple cellular processes such as 
transcription, translation, and remediation pathways such as autophagy (89).  Yeast 
contains two homologous TOR protein kinases, Tor1p and Tor2p, which form two 
distinct complexes, designated TOR complex 1 (TORC1) and TOR complex 2 (TORC2), 
both of which have parallel functions in mammalian cells (119).  TORC1 consists of 
Kog1 (Raptor), Lst8, Tco89, and either TOR1 or TOR2 protein kinase.  TORC2 is 
composed of only TOR2 and Lst8, Avo1, Avo2, Avo3 (Rictor), Bit2, and Bit61.  Many 
of the proteins present in yeast TORCs have direct homologues in higher eukaryotes 
(121).  The macrocyclic lactone rapamycin, when bound to its FKBP12 receptor (Fpr1p 
in yeast) inhibits the nutrient sensitive TORC1 (Fig. 5), but not TORC2 (122-124).  In an 
interesting parallel between yeast and mammals, TORC1 phosphorylates Sch9p to 
regulate ribosomal protein gene expression, analogous to activation of S6K1 in mammals 
(125).  While TORC2 has been shown to activate Ypk2p, an AGC family kinase required 
for actin polarization (126), similar to activation of PKB/Akt (127). 
Nitrogen metabolism is a particularly important pathway regulating TOR function 
in yeast (128-129).  Yeasts are capable of using some 30 different compounds as a 
nitrogen source including ammonia and all twenty amino acids (130).  Thus, all nitrogen-
containing constituents of the cell can be derived from degradation of a carbon source 
and these compounds (131).  Among these many compounds, glutamine is the preferred 
nitrogen source and represents a key intermediate in nitrogen metabolism (131).  The  
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Figure 5.  TOR is a key regulator of nutrient-sensitive transcription factors.  The 
immunosuppressant drug rapamycin binds to FKBP (Fpr1p in yeast) which in turn 
inhibits TORC1.  TOR regulates the activity of transcription factors involved in stress 
responses in yeast including Rtg1/3p (retrograde signaling, TCA cycle), Gln3p (nitrogen 
discrimination), Gcn4p (general amino acid control), Msn2/4p (carbon limitation), and 
Sfp1p (ribosomal protein gene expression).  Starvation for key nutrients results in relief 
of TOR repression and activation (or inactivation) of these key factors.
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general strategy utilized by yeast following uptake of these nitrogenous molecules is 
catabolism to yield nitrogen in the form of ammonium, glutamate, or both (130-132).  
Glutamine is synthesized from glutamate and ammonium by glutamine synthetase, the 
product of the GLN1 gene.  TORC1 is central for selecting which nitrogen source in the 
media will be utilized.  When the preferred glutamine, or in some strains ammonia, is 
available, yeast cells will not catabolize poorer nitrogen sources, a phenomenon referred 
to as nitrogen catabolite repression or nitrogen regulation (131).  TORC1 regulates many 
nutrient-sensitive transcription factors (128) (Fig. 5).  TORC1 functions to regulate the 
nuclear translocation/activity of stress-responsive TFs such as Msn2/4p following carbon 
limitation and Rtg1/3p known to regulate TCA cycle enzymes in response to 
mitochondrial defects (133).  In addition, TORC1 controls localization of several TFs 
such as Sfp1p, critical for control of expression of ribosomal protein genes (134).  Central 
to this nitrogen selectivity is TORC1 regulation of the GATA family of transcription 
activators, such as Gln3p, which direct the expression of genes encoding permeases and 
catabolic enzymes required for utilization of the secondary nitrogen sources (135).  
Repression of TORC1 in response to changes in nitrogen quality or treatment with 
rapamycin leads to Gln3p translocation to the nucleus and activation of Gln3p-target 
genes (135).  Described in more detail below, translational expression of GCN4 mRNA is 
controlled by TORC1 regulation of GCN2p protein kinase. 
While the mechanisms by which nutrient depletion regulates the TOR pathway 
are not completely understood, sensing of nutrient stress by the GAAC is known to 
involve direct monitoring of uncharged tRNAs that accumulate during amino acid 
depletion (13,18,24).  As described in detail above, uncharged tRNA binds to a 
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regulatory region in Gcn2p homologous to histidyl-tRNA synthetase (HisRS) enzymes, 
producing a conformational change that activates the eIF2 kinase.  In yeast, regulation of 
Gcn2p is also suggested to involve TORC1.  Rapamycin can induces Gcn2p 
phosphorylation of eIF2 by a mechanism involving release of inhibitory phosphorylation 
of Gcn2p at serine-577 (14).  TORC1 is thought to indirectly facilitate the inhibitory 
Gcn2p phosphorylation by a mechanism involving an unknown protein kinase and by the 
type 2A-related protein phosphatase (PPase), Sit4p (14).  In the later regulatory scheme, 
rapamycin would release TORC1 inhibition of Sit4p, allowing for dephosphorylation of 
Gcn2p.  Therefore, at least in the case of rapamycin treatment, there is coordinated 
regulation between the TOR and GAAC pathways.  However, whether or not Gcn4p 
plays a key role in TOR-mediated gene expression is not known.  This latter question is a 
key focus of this dissertation. 
Although a clear connection between TOR and Gcn2p protein kinase in yeast has 
been established, less is known about the regulation of GCN2 by mammalian TOR.  
Recent studies from this laboratory have shown that a reduction in 4E-BP and S6K1 
phosphorylation (two key downstream targets of mTOR (136)) following leucine 
starvation is blocked in liver from Gcn2
-/-
 mice (137).  This suggests that there is a direct 
or indirect linkage between activation of the GCN2 and mTOR pathways in mammalian 
cells starved for essential amino acids.  Mammalian TOR (mTOR) is regulated by diverse 
stress conditions by a mechanism involving inhibitory TSC1 and TSC2 proteins (138).  
Increased translation in Tsc2
-/-
 mouse embryo fibroblasts was shown to induce 
endoplasmic reticulum (ER) stress, activating the eIF2α kinase PERK/PEK, (139).  In 
this case, it is suggested that elevated protein synthesis overwhelms the ER processing 
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capacity, leading to elevated levels of malfolded protein and activation of PERK and the 
associated unfolded protein response.  Interestingly, recent work in Drosophila has 
shown that RNAi knockdown of dGCN2 suppresses the increased cell size associated 
with knockdown of Tsc2 (140).  Thus, while the underlying mechanisms are still not fully 
understood, these results suggest that eIF2α kinases may also be integrated with the 
mTOR pathway to control gene expression. 
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METHODS 
I. Construction of yeast strains and culture conditions 
The S. cerevisiae strains used in this study are listed in Table 1 and all are derived 
from EG328-1A (141).  Strains deleted for GCN2 or GCN4 or with a substitution of 
serine 51 in eIF2α (SUI2-S51A) have been described previously (45).  All other knock-
out strains were constructed by PCR-mediated gene replacement, which removed the 
entire coding region (142).  For Kan-marked strains, deletion cassettes were amplified by 
PCR using genomic DNA from the corresponding deletion mutant in the BY4741 strain 
background (143) that was purchased from Research Genetics or Open Biosystems 
(Huntsville, AL).  Rapamycin, L-methionine sulfoximine (MSX), and all amino acid 
supplements were obtained from Sigma (St. Louis, MO) and 3-aminotriazole (3-AT) was 
purchased from Fluka Chemical (Milwaukee, WI). 
To minimize any unintended nutrient imbalances, we utilized isogenic strains 
which were prototrophic (Table 1).  Cells were cultured in synthetic medium (SD) 
containing 2% dextrose and 0.5% ammonium sulfate (144) and supplemented with all 
amino acids except histidine (SC).  This culture arrangement ensured that cells were 
saturated with amino acids, allowing for similar growth of strains defective for GAAC 
and TOR pathways.  Because 3-AT inhibits the synthesis of histidine, we deleted this 
amino acid from the non-stressed and rapamycin-treated cultures as well.  Omission of 
this amino acid did not alter gene expression as judged by RT-PCR analysis of mRNA, 
such as HIS4 and GAP1 (Fig. 6).  In experiments which analyzed the role of the GAAC 
and TOR pathways in nitrogen assimilation, amino acids were omitted, and alternative 
nitrogen sources (phenylalanine or -aminobutyric acid (GABA), each at concentrations 
48 
 
of 10 mM) were substituted for ammonia in the SD medium, as indicated.  For some 
experiments, cells. were grown in YPD medium containing 1% yeast extract, 2% 
peptone, and 2% glucose, as indicated  (144). 
 
 
 
TABLE 1.  Strains used in this study 
 
 Strain Genotype Reference 
EG328-1A MATα ura3-52 leu2 trp1      (141) 
RY139 MATα ura3-52 gcn2Δ::LEU2 trp1       (45) 
RY290-3 MATα ura3-52 gcn4Δ::LEU2 trp1       (45) 
RY287 MATα ura3-52 gcn4Δ::LEU2 trp1 SUI2::S51A       (45) 
WY837 MATα ura3-52 LEU2 TRP1 This study 
WY838 MATα ura3-52 gcn2Δ::LEU2 TRP1 This study 
WY839 MATα ura3-52 gcn4Δ::LEU2 TRP1 This study 
WY840 MATα ura3-52 LEU2 gln3Δ::TRP1 This study 
WY841 MATα ura3-52 gcn2Δ::LEU2 gln3Δ::TRP1 This study 
WY842 MATα ura3-52 gcn4Δ::LEU2 gln3Δ::TRP1 This study 
WY798 MATα URA3 LEU2 TRP1 This study 
WY799 MATα URA3 gcn2Δ::LEU2 TRP1 This study 
WY857 MATα URA3 gcn4Δ::LEU2 TRP1 This study 
WY858 MATα URA3 LEU2 gln3Δ::TRP1 This study 
WY859 MATα URA3 gcn2Δ::LEU2 gln3Δ::TRP1 This study 
WY860 MATα URA3 gcn4Δ::LEU2 gln3Δ::TRP1 This study 
WY895 MATα URA3 LEU2 TRP1 aro80Δ::kanMX4 This study 
WY962 MATα ura3-52 LEU2 TRP1 aro80Δ::kanMX4 This study 
WY937 MATα URA3 gcn2Δ::LEU2 TRP1 aro80Δ::kanMX4 This study 
WY938 MATα URA3 gcn4Δ::LEU2 TRP1 aro80Δ::kanMX4 This study 
WY933 MATα URA3 LEU2 TRP1 uga3Δ::kanMX4 This study 
WY939 MATα URA3 LEU2 TRP1 sit4Δ::kanMX4 This study 
WY963 MATα URA3 LEU2 TRP1 uga1Δ::kanMX4 This study 
WY936 MATα ura3-52 LEU2 TRP1 uga3Δ::kanMX4 This study 
WY964 MATα ura3-52 LEU2 TRP1 uga1Δ::kanMX4 This study
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II. Construction of plasmids 
Plasmids p180 and p227 have been described previously (145).  All other lacZ 
reporter plasmids are derivatives of pRS416-lacZ which contains a lacZ cassette 
subcloned into the HindIII/XhoI site of pRS416 (146).  The PGCRE-lacZ reporter plasmid 
was derived from plasmid pME1112 (147).  Briefly, six copies of the GCRE were 
amplified by PCR and subcloned upstream of a minimal CYC1 promoter in the reporter 
plasmid p416-CYC1TATA-lacZ.  The PGATA-lacZ reporter plasmid contains two copies of 
a consensus GATA (GATAAG) derived from the GLN1 gene (148).  The PARO9-lacZ, 
PUGA3-lacZ, PUGA1-lacZ reporter plasmids contain the complete upstream noncoding 
sequences of the ARO9 (-608 to -1), UGA3 (-677 to -1), and UGA1 (-548 to -1) genes, 
respectively.  These DNA segments were subcloned into the XbaI/EcoRI site of pRS416-
lacZ.  Deletions of the UGA3 promoter (-371, -300, -200, and -103) were constructed by 
PCR.  Site-directed mutagenesis of the minimal UGA3 promoter (-300 to -1) was carried 
out by PCR with oligonucleotides containing the specific nucleotide changes as indicated 
(Table 2).  Plasmid p722 encodes wild-type GCN2 and the selectable URA3 gene (60), 
and p299 includes the mutant version, gcn2-m2, which has Y1199L and R1120L 
substitutions in the HisRS-related domain of Gcn2p, which block binding to uncharged 
tRNA (15,21).  Plasmid pYB41 encoding a GCN4-lacZ reporter with a selectable TRP1 
gene was described previously (26,45).  Plasmid p1024 (ADH-GCN4-flag) encodes a 
constitutive (GCN4
c
) carboxy-terminal flag-tagged allele of GCN4 subcloned into the 
XbaI/XhoI site of p416ADH (149).  Plasmid p1025 (GCN4-flag) contains the GCN4 
ORF encoding a carboxy-terminal flag epitope and its upstream regulatory sequences (-
1000 to -1) subcloned into the XbaI/XhoI site of pRS416 (146).  All oligonucleotides 
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utilized to construct the above plasmids are described below in Table 2.  The nucleotide 
sequences of all amplified regions were confirmed by nucleotide sequencing.  All 
plasmids used in these studies are listed in Table 3. 
 
 
 
TABLE 2.  Oligonucleotides used to construct plasmids used in these studies 
Oligo Description Sequence
a
 
kwp404 ARO9 promoter GCTCTCTAGAGGGAAGTCATAGTAATAGAT 
kwp405 ARO9 promoter GCTCAAGCTTTGAGTCGATGAGAGAGTGTA 
kwp417 UGA3 promoter GCTCTCTAGAGCTTTCTTTTCTAATTCT 
kwp418 UGA3 promoter GCTCGAATTCACCTCACTTTAAAAAACT 
kwp429 UGA1 promoter GCTCTCTAGAGAAATGTCAATCATTATTGC 
kwp430 UGA1 promoter GCTCGAATTCTGTTCTTAGTTATATTTC 
kwp531 UGA3 promoter -371 to -1 GCTCTCTAGAAACAATAGGACGAAAAAT 
kwp532 UGA3 promoter -300 to -1 GCTCTCTAGATATATTTTTTTTTTGGGC 
kwp533 UGA3 promoter -200 to -1 GCTCTCTAGAGGAGCCAATCGGATTGAC 
kwp549 UGA3 promoter -103 to -1 GCTCTCTAGAAAAGAAAAAGAAATTACAAT 
kwp550 mutagenesis of GATA site GAAAAATGTGCAAAAGAGATCTGGAGCCAATCGGATTG 
kwp551 mutagenesis of GATA site CAATCCGATTGGCTCCAGATCTCTTTTGCACATTTTTC 
kwp552 mutagenesis of GCRE site TAGGGCTACCAGGGTCCGTCGACTCAAAGAAAAAGAAAT 
kwp553 mutagenesis of GCRE site ATTTCTTTTTCTTTGAGTCGACGGACCCTGGTAGCCCTA 
a
Sequences in bold indicate restriction sites or nucleotides altered by site-directed 
mutagenesis.
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TABLE 3.  Plasmids utilized in these studies 
Name Description 
p180 low copy URA3 containing GCN4-uORFs-lacZ reporter 
p227 low copy URA3 containing GCN4-ΔuORFs-lacZ reporter 
pME1112 integrating plasmid containing GCRE6-lacZ reporter 
pRS416 low copy URA3 plasmid 
p416-CYC1TATA-lacZ lacZ promoter with minimal CYC1 promoter 
p416GCRE-lacZ low copy URA3 containing GCRE lacZ reporter 
p416GATA-lacZ low copy URA3 containing GATA lacZ reporter 
pRS416-lacZ low copy URA3 containing lacZ reporter gene 
p416ARO9-lacZ low copy URA3 lacZ reporter containing ARO9 promoter 
p416UGA3-lacZ low copy URA3 lacZ reporter containing UGA3 promoter 
p416UGA1-lacZ low copy URA3 lacZ reporter containing UGA1 promoter 
p416UGA3-371-lacZ deletion of UGA3 promoter (-677 to -370) lacZ reporter 
p416UGA3-300-lacZ deletion of UGA3 promoter (-677 to -301) lacZ reporter 
p416UGA3-200-lacZ deletion of UGA3 promoter (-677 to -201) lacZ reporter 
p416UGA3-103-lacZ deletion of UGA3 promoter (-677 to -104) lacZ reporter 
p416UGA3-300- m1-lacZ contains mutation in GATA site at -206 of UGA3 promoter 
p416UGA3-300- m2-lacZ contains mutation in GCRE site at -112 of UGA3 promoter 
p416UGA3-300- m3-lacZ contains mutations in GATA and GCRE sites of UGA3 promoter 
p722 low copy URA3 plasmid containing wild-type GCN2 allele 
p299 low copy URA3 plasmids containing M2 mutant allele of GCN2 
pYB41 low copy TRP1 containing GCN4-uORFs-lacZ reporter 
p1024 low copy URA3 plasmid containing ADH-GCN4-flag (GCN4
c
) 
p1025 low copy URA3 plasmid containing GCN4-flag 
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III. Microarray and sequence analysis 
Transcriptome analysis was carried out using RNA prepared from cells treated for 
1 hour with 10 mM 3-AT, 200 nM rapamycin, or no stress, in quadruplicate as indicated.  
The 1 hour incubation time was shown to induce maximal expression of HIS4 and GAP1 
mRNAs as judged by RT-PCR analysis (Fig. 6).  RT-PCR analysis was conducted using 
Superscript one-step RT-PCR with Platinum Taq polymerase (Invitrogen, Carlsbad, CA).  
 
 
 
 
 
 
 
Figure 6.  RT-PCR analysis of HIS4 and GAP1 transcripts in cells treated with 3-AT 
or rapamycin.  Semi-quantitative RT-PCR measurements of HIS4, GAP1, or ACT1 
mRNAs were carried out in wild-type (WY798) cells treated with 10 mM 3-AT (3AT), 
200 nM rapamycin (Rap), or no treatment (C, control) for 0.5, 1, or 2 hours as indicated.  
The resulting PCR products were analyzed on a 2% agarose gel and visualized following 
ethidium bromide staining. 
  
C 3AT Rap C 3AT Rap C 3AT Rap
HIS4
GAP1
ACT1
0.5 1 2 :time (hr)
:treatment
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Four independent cultures of strains WY798 (wild-type), WY799 (gcn2Δ), WY857 
(gcn4Δ), WY858 (gln3Δ), WY859 (gcn2Δ gln3Δ) and WY860 (gcn4Δ gln3Δ) were 
cultured as described above and total RNA was purified using the hot phenol method 
(150).  The RNA was labeled using the standard Affymetrix protocol for 3'-IVT arrays 
(Affymetrix, Santa Clara, CA).  Labeled cRNA was hybridized for 17 hours to Yeast 
Genome S98 GeneChips .  Signal values and detection calls were generated using 
Affymetrix Microarray Suite 5.0.  Arrays were scaled to a target intensity of 1000 and 
detection calls were generated using the default parameters. Average signal intensities 
from four independent experiments for each of the eighteen treatment groups were 
compared by performing a Welch’s unpaired t-test (151), and false discovery rates (FDR) 
were calculated according to Benjamini and Hochberg (152).  The fold change ratios and 
p values for each probe set and FDR values for each comparison are listed in 
supplemental Table S1 (153).  Microarray data have been deposited in GEO 
(http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE15254.  Pearson and 
Spearman correlations were calculated using GraphPad Prism version 4.03 (San Diego, 
CA).  The mRNA changes for select genes which were derived from the microarray 
analyses were independently confirmed by qRT-PCR using SYBR green.  Briefly, cDNA 
was synthesized using 1 µg of total RNA and 2.5 µM random hexamers in the RT 
mixture according to the manufacturer’s protocol (Applied Biosystems, Foster City, CA).  
Quantitative PCR reactions consisted of 2.5 µl RT product, 400 nM primers, and 1X 
SYBR  Green PCR master mix (Applied Biosystems, Foster City, CA).  Reactions were 
incubated for one initial cycle at 50 °C for 2 minutes and 95 °C for 10 minutes followed 
by 40 cycles of 95 °C for 15 seconds and 60 °C for 1 minute.  Primers were designed 
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using PrimerExpress software (Applied Biosystems, Foster City, CA).  The nucleotide 
sequences of the primers used to quantitate the ARO9, ARO10, and PDC6 genes, as well 
as those specific to the ACT1 gene used for internal normalization, were described by 
Chen and Fink (154). 
Gene list comparisons were performed using the compare classes utility provided 
by the Regulatory Sequence Analysis Tools (http://rsat.ubl.ac.be/rsat/) (155). 
Comparisons were made with previous 3-AT and rapamycin data sets (79,134) and to 
several predefined gene lists, such as genes induced by promoters bound in chromatin 
immunoprecipitation (ChIP-chip) experiments (156), genes in the MIPS functional 
catalogue (157), Gene Ontology categories (158), as described by Godard et al. (159).  
The significance of overlap between gene lists was quantitatively determined by the 
hypergeometric distribution (160) using the number of probe sets on the S98 array as the 
population size or by calculating the representation factor (161) using the web utility 
Microarray Analysis Tools (http://elegans.uky.edu/MA/).  Upstream noncoding 
regulatory sequences were retrieved and analyzed using Regulatory Sequence Analysis 
Tools (155).  The program dna-pattern was used to search for and catalogue occurrences 
of consensus GCRE (TGABTVW) and GATA (GATAAG, GATAAH, GATTA) motifs 
in yeast promoters.  The program oligo-analysis (162) was used to search the promoter 
regions of co-regulated genes for overrepresented sequence motifs.  Analysis of the 5’-
noncoding regions of the Gcn4p-dependent activation core (GAC) identified the 
consensus GCRE motif (TGABTVW).  Information pertaining to specific gene functions 
and biological processes was obtained from the Saccharomyces Genome Database (SGD, 
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http://www.yeastgenome.org) or the MIPS Comprehensive Yeast Genome Database 
(CYGD, http://mips.gsf.de/genre/proj/yeast). 
 
IV. Immunoblot analysis 
Yeast cells were cultured as described above, collected by centrifugation, washed 
with ice-cold water, and resuspended in a solution of ice-cold 20 mM sodium phosphate 
[pH 7.2], 50 mM NaCl, 5 mM EDTA, 1 mM DTT, protease inhibitors (100 µM PMSF, 
0.15 µM aprotinin, 1 µM leupeptin and 1 µM pepstatin), and phosphatase inhibitors (50 
mM NaF and 40 mM β-glycerophosphate).  Cells were lysed by vortexing 3-5 times for 
30 seconds with glass beads, followed by centrifugation to clarify the lysate.  The protein 
content of the cell lysate was measured using the Bradford method (163).  Equal amounts 
of each protein sample were separated by electrophoresis in a SDS-polyacrylamide gel, 
and transferred to nitrocellulose filters.  Immunoblot analyses were carried out using a 
polyclonal antibody that specifically recognizes phosphorylated eIF2α at Ser-51 
(Research Genetics or StressGen) or M2-FLAG epitope tag (Sigma, St. Louis, MO).  
Total eIF2α levels were measured using a rabbit polyclonal antibody against recombinant 
yeast eIF2α (45). 
 
V. LacZ enzyme assays 
Yeast cells expressing lacZ reporter genes were grown to early logarithmic phase 
in SD or SC medium and treated as indicated.  Following incubation at 30 °C, the non-
stressed cells were harvested after 4 hours, and stressed cells were collected after 6 hours, 
as described previously (45).  Cells were collected by centrifugation, resuspended in 250 
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µl of ice-cold breaking solution (100 mM Tris-HCl [pH 8.0], 20% glycerol, 1mM β-
mercaptoethanol and 100 µM PMSF), and broken by vortexing 3-5 times for 30 seconds 
with glass beads, followed by centrifugation at 15,000 x g to clarify the lysates.  To 
measure the β-galactosidase activity, 5 – 50 µl of extract was added to 950 – 995 µl of Z-
buffer (100 mM sodium phosphate [pH 7.5], 10 mM KCl, 2 mM Mg2SO4, 4.5 mM β-
mercaptoethanol), and the reaction was initiated by the addition of 200 µl solution of o-
nitrophenyl-β-D-galactopyranoside (4 mg/ml ONPG in Z-buffer).  The reaction was 
terminated following a 10 – 20 minute incubation at 30 °C by adding 0.5 ml of 1 M 
Na2CO3, and the absorbance of the reaction mixture was measured at A420.  Specific 
enzyme activity is represented as nanomoles of ONPG hydrolyzed per minute per 
milligram of total protein (nmole/mg/min).  Total protein concentration of the clarified 
lysate was determined using the Bradford method (163).  The average β-galactosidase 
activity ± S.E. from 2 – 3 independent cultures is presented for each experiment.  
Statistical significance was determined by Student's t test. 
 
VI. Polysome analysis 
Ribosomal profiles were generated using sucrose gradient centrifugation as 
described previously (15).  Briefly, wild-type or gcn2Δ cells were grown in SD medium 
containing ammonia as the sole nitrogen source and harvested in mid-logarithmic phase.  
Alternatively, these cells were shifted from SD to GABA medium, cultured for 1 hour, 
and harvested.  Just prior to harvesting, cycloheximide was added to a final concentration 
of 50 µg/ml to retain polysomes as described (39).  Lysate preparation and sucrose 
gradient analyses were carried out as described previously (39-40).  In addition to 
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cycloheximide, cells lysate preparations contained 10 mM MgCl2, required for 
association of ribosomal subunits.  Aliquots of 20.–.25 A260 units were applied to 11.5 ml 
of 10–50% sucrose gradients and subjected to centrifugation at 40,000 rpm for 2 hours in 
a Beckman SW41 rotor at 4 °C. 
 
VII. Measurement of tRNA charging 
Yeast cells were grown in SD medium and shifted to synthetic medium containing 
GABA as the sole nitrogen source for 15 minutes or 60 minutes, as indicated.  Cells were 
collected by centrifugation, and tRNA preparations were prepared and analyzed for tRNA 
charging genome-wide, as described (22).  This method involves preparation of RNA 
from the collected cells using mild acidic conditions, which allow retention of charged 
tRNAs.  The RNA samples were then divided into two equal portions.  One part was 
treated with periodate, which selectively oxidizes uncharged tRNA and selectively blocks 
their subsequent ligation to a fluorophore-labeled oligonucleotide.  The second portion 
was not treated with periodate, which allows both charged and uncharged portions to be 
subsequently ligated to the labeled oligonucleotide.  Both tRNA preparations were then 
deacylated using alkaline pH.  A fluorescent-tagged oligonucleotide, which contains a 
stem-loop structure with a portion complementary to the 3'-CCA sequence that is 
conserved among all tRNAs, was ligated to only those tRNAs with intact 3’-ends.  Both 
samples were labeled with Cy3 or Cy5 fluorophore, and after fluorescent labeling, the 
tRNA preparations with opposite fluorophores, such as charged tRNA with Cy5 and total 
tRNA with Cy3, were combined and hybridized to microarrays.  The labeled tRNA 
preparations were hybridized to custom-made microarrays, which contained multiple 
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replicates for each probe, as described (22).  Two microarray analyses were carried out 
for each sample to minimize dye-bias, the first microarray used Cy5-labeled charged 
tRNA and Cy3-labeled total tRNA, while the second microarray used Cy3-labeled 
charged tRNA and Cy5-labeled total tRNA.  The array results were presented as 
histograms of the average relative charging levels ± S.E., with the relative charging level 
between cells grown in SD medium compared that that cultured in GABA containing 
medium.  The tRNAs were grouped according to amino acid properties (hydrophobic, 
small, charged, polar).  Each tRNA measurement was derived from three independent 
culture preparations and data analysis and statistics were provided by the scanner 
software (Axon Instruments, Foster City, CA) and the median values of dye ratios for 
each array probe are presented.  In parallel, Northern analyses were performed using 
6.5% polyacrylamide acid denaturing gels to separate charged from uncharged tRNAs, as 
described (164).  As a control, tRNAs were deacylated, and the tRNAs were then 
transferred to filters and hybridized to radiolabeled probe complementary to tRNA
Phe
 
(22). 
  
59 
 
RESULTS 
I.  Defects in the GAAC and TOR pathways alter growth during nutrient stress 
To address the coordination of the GAAC and TOR pathways in the regulation of 
the transcriptome in response to nutrient stress, we constructed a set of isogenic strains 
that were deleted for the entire coding region of GCN2, GCN4, and GLN3, individually 
or in combination (gcn4Δ gln3Δ and gcn2Δ gln3
strain EG328-1A, which has a robust nutrient stress response, and each strain was 
prototrophic for amino acid biosynthesis (Table 1).   
Deletion of GLN3 renders cells sensitive to MSX, an inhibitor of glutamine 
synthetase, which is consistent with the idea that GLN3 is central for gene expression 
directed by the TOR pathway in response to nutrient stress (Fig. 7A) (90).  By contrast, 
deletion of GLN3 renders cells more resistant to rapamycin (Fig. 7A), implying that 
Gln3p alters genes contributing to control of the cell cycle and proliferation (129). 
Consistent with their important roles in the GAAC, deletion of either GCN2 or 
GCN4 resulted in growth sensitivity to 3-AT, a potent inhibitor of histidine biosynthesis 
(Fig. 7A).  Deletion of GLN3 led to a partial reduction in growth in the presence of 3-AT, 
suggesting that this transcription activator may function in conjunction with Gcn4p for 
expression of certain biosynthetic genes.  Loss of either GCN2 or GCN4 alone resulted in 
increased resistance to rapamycin (Fig. 8A).  Combined deletion of GCN2/GLN3 or 
GCN4/GLN3 resulted in further resistance that was comparable to the level seen in a 
dominant TOR1 mutant (TOR1-S1972I), which does not bind the Fpr1p/rapamycin 
complex (Fig. 8A) (165-166).  Therefore, the combined deletions prevent blockade of  
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Figure 7.  GCN2 is required for induced Gcn4p transcriptional activity in response 
to rapamycin or 3-AT treatment.  (A) Growth of prototrophic yeast strains were 
determined by streaking onto YPD agar medium (YPD) or YPD containing 2 mM MSX 
(MSX) or 200 nM rapamycin (RAP), as indicated.  Strains were also streaked on 
synthetic complete (SC) media (lacking histidine) containing 30 mM 3-AT (3-AT).  (B) 
Wild-type and gcn2Δ cells were treated with 10 mM 3-AT (3AT), 200 nM rapamycin 
(Rap), or no stress (C, control) for 1 hour, and the levels of eIF2  phosphorylated 
specifically at serine-51, or total eIF2α, were measured by immunoblot analyses.  (C) 
Yeast cells containing a PGCRE-lacZ reporter plasmid including the consensus GCRE were 
treated with 3-AT or rapamycin, as listed in the legend.  The average β-galactosidase 
activity from three independent cultures ± S.E. is shown. 
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Figure 8.  Loss of the GAAC renders cells growth resistant to rapamycin.  (A) Wild-
type cells, or mutant cells containing the indicated gene mutations, were streaked on YPD 
agar plates containing 200 nM rapamycin (Rap), 2 mM L-methionine sulfoximine 
(MSX), or no stress treatment (YPD).  As a control, strains were also grown on synthetic 
complete media lacking histidine and lacking histidine and containing 30 mM 3-amino-
triazole (3-AT).  A GCN4-lacZ reporter plasmid (GCN4-uORFs-lacZ) with (B) or 
without (GCN4-ΔuORFs-lacZ) uORFs (C) was introduced into wild-type cells (WY837), 
or cells deleted for GCN2 (WY838), GLN3 (WY840), or GCN2 and GLN3 (WY841), as 
indicated.  Cells were treated with 3-AT or rapamycin for 6 hours, and β-galactosidase 
activity was measured from whole cell extracts.  ***, denotes a significant reduction (p < 
0.001) in β-galactosidase  activity in gln3Δ cells treated with rapamycin compared to 
wild-type cells treated with rapamycin.  The average β-galactosidase activity from three 
independent cultures ± S.E. is shown.
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TOR function by rapamycin, even in the presence of the functional TOR2 locus.  
These results support the idea that the two major nutritional stress pathways can work 
in synergy, with both GCN2 and GCN4 contributing to gene expression mediated by 
the TOR signaling pathway. 
 
II. Rapamycin induces Gcn2p phosphorylation of eIF2α and Gcn4p-
mediated transcription 
Treatment of the wild-type strain with either 3-AT or rapamycin increased 
Gcn2p-dependent phosphorylation of eIF2α and GCN4 translational control, as 
measured by a lacZ reporter fused to the 5'-leader of the GCN4 mRNA (Figs. 7B and 
8B) (14-16).  Deletion of GCN2 blocked GCN4 expression in response to either 
stress, while gln3Δ cells showed a modest, but significant (p < 0.001), decrease in 
GCN4 expression in response to rapamycin exposure (Fig. 8B).  Consistent with the 
idea that the GAAC regulates translation via uORFs in the 5’-leader of the GCN4 
mRNA, high levels of GCN4 expression were measured in cells containing a similar 
lacZ reporter devoid of the GCN4 uORFs independent of the stress treatment (Fig. 
8C). 
Importantly, elevated eIF2α phosphorylation and GCN4 translation triggered 
increased Gcn4p-directed transcription as measured by a lacZ reporter containing a 
minimal CYC1 promoter containing consensus Gcn4p-binding sites (GCREs) (Fig. 
7C).  Gcn4p transcriptional activity was blocked by deletion of either GCN4 or GCN2 
(Fig. 7C).  Interestingly, cells devoid of GLN3 increased Gcn4p transcriptional 
activity by an additional 2-fold in response to 3-AT, suggesting an underlying 
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compensatory system in which loss of portions of the TOR pathway further enhance 
the GAAC. 
 
III.  Gcn4p is a major contributor to TOR-mediated gene expression 
1. Changes in the yeast transcriptome following treatment with 
3-AT or rapamycin 
To address the roles of Gcn4p and Gln3p in gene expression induced by either 
3-AT or rapamycin treatment, we carried out whole genome transcriptional profiling 
experiments using Affymetrix GeneChips to measure mRNA levels in an isogenic set 
of strains (Fig. 9 and Table 1).  Cells deleted for GCN2, GCN4 or GLN3, or their 
combined mutations (gcn2Δ gln3Δ and gcn4Δ gln3Δ), were cultured for 1 hour in the 
presence of either 10 mM 3-AT or 200 nM rapamycin and compared to a wild-type 
strain that was similarly treated.  Of the genes that were defined by probe sets, a 
significant (p ≤ 0.05, FDR ≤ 0.2) change in expression was observed in >5100 probe 
sets (out of 9275 on the S98 array) representing 4052 uniquely annotated genes.  A ≥ 
2-fold increase was observed in 2532 probe sets representing 2103 uniquely 
annotated genes (total of increases and decreases; Fig. 10A).  This indicates that a 
substantial portion of the yeast transcriptome, ~30% of the encoded genes, is 
regulated by either amino acid starvation or rapamycin-mediated inactivation of the 
TOR pathway.  
2. Genes induced by 3-AT 
In cells exposed for 1 h to 10 mM 3-AT, there was ≥ 2-fold increased 
expression of 1029 genes (700 annotated, Table 4), which correlates well with those  
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Figure 9.  Design of whole genome transcriptional profiling experiments in yeast.  
The microarray experiment included 18 treatment groups involving six isogenic yeast 
strains and three treatment conditions.  Wild-type (WT), and relevant gene deletions 
are indicated.  Strains were grown in SC media lacking histidine and treated with 10 
mM 3-AT (3AT), 200 nM rapamycin (Rap), or no stress (Control) for 1 hour. 
  
Strain Genotype Control 3AT Rap
WY798 WT 1 2 3
WY799 gcn2 4 5 6
WY857 gcn4 7 8 9
WY858 gln3 10 11 12
WY859 gcn2 gln3 13 14 15
WY860 gcn4 gln3 16 17 18
Treatment
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Figure 10.  The role of GAAC and TOR in the changes of the yeast 
transcriptome following treatment with rapamycin or 3-AT.  (A) Venn diagrams 
illustrating the number of genes whose encoded mRNAs require GCN2, GCN4, or 
GLN3 for a 2-fold change in expression following 3-AT or rapamycin treatment.  Red 
indicates those gene transcripts changed only by 3-AT, green only in response to 
rapamycin treatment, and yellow by both stress treatments.  The total number of 
transcripts changed for each mutant and the percentage of the total number of 
transcripts changed in the wild-type strain are indicated at the right of the figure.  (B) 
(Top) Venn diagram illustrating the number of genes whose encoded mRNAs require 
GCN4 or GLN3 for a ≥ 2-fold increase following rapamycin exposure.  Red indicates 
those gene transcripts requiring only GCN4, green requiring only GLN3, and yellow 
requiring both transcriptional regulators.  (Bottom) Rapamycin-induced fold-changes 
for gene transcripts in wild-type, gcn4Δ, gln3Δ, or gcn4Δ gln3Δ are plotted 
individually in black.  The average fold-change for all gene transcripts is shown in 
red and the fold-change values for UGA3 mRNA are highlighted in green.  Heat maps 
illustrate the levels of gene transcripts which require GCN4 for increased (C) or 
decreased (D) expression following treatment with 3-AT or rapamycin.  Genes in the 
Gcn4p activation or repression core are listed, along with their general biological 
functions.  The legend at the bottom of the heat maps illustrates the changes in 
transcript levels between the paired samples listed at the top of each map.  The 
number of GCREs present in each gene promoter region is represented to the right of 
the heat maps.  In Fig. 10C, the asterisks indicate promoters reported to bind Gcn4p 
in chromatin immunoprecipitation (ChIP-chip) experiments (156), and genes 
highlighted in blue were reported to have increased transcription in medium 
supplemented with secondary group B nitrogen compounds (159).
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genes (both identity and magnitude of induction) reported to be induced by treatment 
with 100 mM 3-AT (79) (Fig. 11A).  A histogram depicting the distribution of the 
fold-changes for these genes is shown in Fig. 11B.  Of the genes induced by 3-AT 
treatment, 209, 223, and 71 were dependent on GCN2, GCN4, or GLN3, respectively 
(Table 4 and supplemental Table S2 (153)).  A large portion of the GAAC-dependent 
genes activated by 3-AT are involved in amino acid metabolism, a major focus for 
Gcn4p (18,79) (supplemental Table S2, (153)).  Using this ≥ 2-fold induction criteria, 
Gcn4p was required for increased expression of 46 amino acid biosynthetic genes, 
participating in the synthesis of each of the amino acids, with the exception of 
proline.  In this later case, Gcn4p was required for a 1.6-fold increase in expression of 
PRO2 (p < 0.001), encoding -glutamyl phosphate reductase (catalyzing the second 
step in the biosynthesis of proline), which although significant was below the ≥ 2-fold 
threshold.  Related to this biosynthetic process, Gcn4p also induced genes involved 
vitamin metabolism (7-targeted genes involved in the biosynthesis of pyridoxal 
phosphate, NAD, folate, coenzyme A, or riboflavin), intermediary metabolism (12 
genes) and transport processes (5 genes) [highlighted in bold red in supplemental 
Table S2, (153)].  It is noteworthy that Gcn4p also plays an important role in nitrogen 
utilization, targeting 12 genes in this functional category.  The mechanistic role of 
Gcn4p in nitrogen utilization will be explored further below. 
Among the genes requiring either GCN2 or GCN4 for full induction, a 
significant majority (77%, Representation Factor = 37.4) of these required both 
regulators of the GAAC, supporting the idea that Gcn2p is a central upstream 
activator of the Gcn4p.  A subset of these (35 genes) were found to be significantly  
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Figure 11.  Comparative analysis of genes induced by 3-AT or rapamycin 
treatment.  (A) A comparative analysis of genes induced or repressed by 3-AT in 
this study (RW01) with those in Set A of Natarajan et al., 2001 (79).  A Log10 scatter 
plot is shown displaying all probe sets representing transcripts which showed a 
significant change (p  0.05, FDR  0.2) in expression following treatment with 10 
mM 3-AT for 1 hour.  Transcripts which correlated positively (2103 total) or 
negatively (206 total) are indicated by black and grey stars, respectively.  A trend line 
is shown in red for those transcripts which displayed a significant positive correlation 
(Pearson r = 0.87, p < 0.0001, Spearman r = 0.85, p < 0.0001).  Transcripts which 
changed by 2-fold or more (-0.33  Log2 ≥ 0.33) are enclosed by blue dotted lines in 
upper right and lower left quadrants.  (B) The distribution of the yeast transcriptome 
following treatment with 3-AT (top panel) or rapamycin (bottom panel) is depicted as 
a histogram indicating the number of genes that were significantly induced or 
repressed (p  0.05, FDR  0.2).  The number of probe sets representing transcripts at 
each value of Log2 ratio are plotted.  (C) A comparative analysis of genes induced or 
repressed by rapamycin in this study (RW01) with those in Marion et al., 2004 (134).  
A Log10 scatter plot is shown displaying all probe sets representing transcripts which 
showed a significant change (p  0.05, FDR  0.2) in expression following treatment 
with 200 nM rapamycin for 1 hour.  Transcripts which correlated positively (2390 
total) or negatively (371 total) are indicated by black and grey stars, respectively.  A 
trend line is shown in red for those transcripts which displayed a significant positive 
correlation (Pearson r = 0.87, p < 0.0001, Spearman r = 0.88, p < 0.0001).  
Transcripts which changed by 2-fold or more (-0.33  Log10 ≥ 0.33) are enclosed by 
blue dotted lines in upper right and lower left quadrants.  (D) A comparative analysis 
of transcripts induced or repressed following treatment with 3-AT or rapamycin.  A 
Log2 scatter plot is shown displaying all probe sets representing mRNAs which 
showed a significant change (p  0.05, FDR  0.2) in expression following treatment 
with 10 mM 3-AT or 200 nM rapamycin for 1 hour.  Transcripts which correlated 
positively or negatively are indicated by black and grey stars, respectively.  A trend 
line is shown in red for those transcripts which displayed a significant positive 
correlation (Pearson r = 0.73, p < 0.0001, Spearman r = 0.78, p < 0.0001).  
Transcripts whose levels changed by 2-fold or more (-1.0  Log2 ≥ 1.0) are enclosed 
by blue dotted lines in upper right and lower left quadrants. 
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TABLE 4.  Summary of gene expression profiling experiments 
 
a
Number of probe sets representing transcripts that increased or decreased 
significantly (p ≤ 0.05, FDR ≤ 0.2) following treatment with 3-AT or rapamycin, and 
the number of these significant probe sets in which the change was at least 2-fold.   
b
Transcripts whose expression is dependent on GCN2, GCN4, or GLN3, identified as 
those showing a ≥ 2-fold (induced genes) or significant change (repressed genes) in 
the comparison between wild-type + treatment vs. either gcn2Δ + treatment, gcn4Δ + 
treatment or gln3Δ + treatment. 
c
Probe sets highlighted in bold are described in supplemental Table S2, (153).
Treatment Dependence
b
 
Number of probe sets
a
 
Increase ≥ 2X increase Decrease ≥ 2X decrease 
3-AT wild-type 2186 1029
c
 1521 443 
3-AT GCN2-dep 541 209 319 85 
3-AT GCN4-dep 579 223 333 93 
3-AT GLN3-dep 383 71 289 129 
      
Rapamycin wild-type 2236 924 1525 732 
Rapamycin GCN2-dep 177 78 93 53 
Rapamycin GCN4-dep 395 115 397 197 
Rapamycin GLN3-dep 526 114 596 396 
76 
 
 
 
 
 
Figure 12.  Requirements for GCN2, GCN4, and GLN3 for changes in gene 
expression in response to 3-AT or rapamycin treatment.  Venn diagrams illustrating 
the number of genes whose encoded mRNAs require GCN2, GCN4, or GLN3, as 
indicated, for a ≥ 2-fold increase (A) or ≥ 2-fold decrease (B) in expression following 3-
AT or rapamycin treatment.  The numbers of transcripts requiring two or all three of 
these regulatory genes for full induction or repression are indicated inside the colored 
overlapping regions. 
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more dependent on GCN4, as defined by those transcripts whose expression was 
increased ≥ 2-fold in wild-type cells treated with 3-AT compared to either the gcn2Δ and 
gcn4Δ mutant strains (Fig. 12A, supplemental Table S2, (153)).  This finding argues that 
even basal amounts of Gcn4p, i.e. the levels of the transcription factor expressed in the 
absence of Gcn2p phosphorylation of eIF2α can be important for directing the 
transcriptome during certain stresses.  Among the GAAC-dependent genes, a smaller 
number of genes showed a greater requirement for GCN2 compared to GCN4 (21 genes) 
using the same criteria (Fig. 12A and supplemental Table S2, (153)).  These genes 
include ARO9 and ARO10, which are involved in a catabolism of aromatic amino acids 
and will be discussed further below. 
The 71 genes requiring GLN3 for induction in response to 3-AT did not overlap 
substantially with those requiring GCN4, with only 10% of the GLN3-dependent gene 
showing a requirement for GCN4 (Fig. 12A and supplemental Table S2 (153)).  The 
largest group of genes requiring GLN3 for induction in response to 3-AT were 
uncharacterized genes (14), followed by those related to transport (5), transcription 
processes (5), and metabolism (3).  Overall, these results support the idea that the TOR-
targeted Gln3p is a significant contributor to changes in the transcriptome in response to 
amino acid deprivation, a finding consistent with the sensitivity of the gln3Δ strain to 3-
AT (Fig. 7A).  However in the case of 3-AT, Gln3p-targeted genes are largely distinct 
from those regulated by Gcn4p. 
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3. Genes repressed by 3-AT 
Fewer genes were repressed by 3-AT treatment (443 repressed ≥2-fold) as 
compared to rapamycin, with a total of 93 genes displaying significant dependence on 
Gcn4p (Table 4 and Fig. 10A).  Included among the genes requiring Gcn4p for repression 
are those involved in protein synthesis, ribosomal proteins and ribosomal biogenesis, and 
well as genes involved in protein folding, targeting and sorting (supplemental Table S2 
(153)).  It is also noteworthy that there was significant overlap among the Gcn4p-
repressed genes and those reduced during the so-called environmental stress response 
(167) (105 out of 261 annotated genes, p < 1.4x10
-43
).  This suggests that Gcn4p-
dependent repression can occur in response to diverse environmental stresses.  
Gln3p contributes to repression of an even larger set of genes compared to Gcn4p 
(129 versus 93; Table 4), and these repressed genes are involved in the same processes as 
described above for Gcn4p.  Of these genes, 44 genes require both Gcn4p and Gln3p, 
suggesting significant regulatory overlap between the genes repressed by the TOR and 
GAAC pathways (Fig. 12B and supplemental Table S2, (153)).  We conclude that Gln3p 
can be a significant contributor to regulation of the transcriptome in response to amino 
acid starvation. 
 
4. Genes induced by rapamycin 
Treatment of cells with rapamycin resulted in 924 transcripts (695 annotated 
genes) being induced ≥ 2-fold, which correlates well with those reported by Marion et 
al.(134) (Fig. 11C).  The distribution of the fold changes for these genes is shown in Fig. 
11B.  There is a moderate correlation (Pearson r = 0.73, Spearman r = 0.78) between 
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those genes regulated by rapamycin and those regulated by 3-AT (Fig 11D).  Of these 
induced transcripts, 115 and 78 genes showed dependence for GCN4 or GCN2, 
respectively (Fig. 10A and Table 4).  Almost a third of the Gcn4p target genes did not 
show significant requirements for GCN2, supporting the idea that basal amounts of 
Gcn4p are significant contributors to the transcriptome in response to rapamycin, an idea 
noted above for 3-AT stress.  The genes induced by Gcn4p in response to rapamycin can 
be divided into two groups.  The first includes 57 genes that were also activated during 3-
AT stress.  We will refer to those genes requiring Gcn4p for induction in response to 
either 3-AT or rapamycin stress as the Gcn4p activation core (Fig. 10C and supplemental 
Table S3, (153)).  As will be discussed further below, the core genes are involved in 
amino acid biosynthesis, nitrogen utilization, intermediary metabolism and cellular 
transport.  The second group includes those Gcn4p-targed genes specifically induced in 
response to rapamycin, which were centered on the generation and utilization of energy-
related compounds (11 genes) (Fig. 10A and supplemental Table S2, (153)).  The 
significant differences between the genes induced by Gcn4p by 3-AT and rapamycin 
indicates that the GAAC transcriptional regulation can be tailored to meet specific stress 
arrangements. 
The number of genes dependent on GCN4 for induced expression during 
rapamycin treatment was similar to those requiring GLN3 (115 versus 114 in Table 4). 
This result demonstrates that Gcn4p has a major role in the induction of TOR-regulated 
genes, comparable to that of the known TOR effector, Gln3p.  An analysis of genes 
requiring both Gcn4p and Gln3p for enhanced expression in response to rapamycin 
indicated that 38 were reduced by the loss of either transcriptional activator (Fig. 10B). 
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When GCN4 and GLN3 were deleted individually or in combination, 24 genes showed 
loss of induction in response to rapamycin stress, as illustrated in Fig. 10B.  The average 
fold change for this collection of genes is illustrated in red.  Many of these genes are 
suggested to carry out catabolic processes (Table 5 and supplemental Table S4, (153)), 
and we will explore further the coordinate regulation of genes involved in GABA 
utilization below.  Paradoxically, among the 38 genes, 14 genes showed full or enhanced 
induction when both GCN4 and GLN3 were deleted, suggesting that there are 
compensatory mechanisms when both are ablated. 
 
5. Genes repressed by rapamycin 
Rapamycin treatment led to ≥ 2-fold repression of 732 genes, with 197 of these 
being dependent on GCN4 (Fig. 10A and supplemental Table S4 (153)).  The largest 
functional classes among the Gcn4p repressed genes are involved in ribosome biogenesis, 
including rRNA processing and modification, protein synthesis, transcription and 
nucleotide metabolism (supplemental Table S2, (153)).  Although these genes overlap in 
their functional classes with those repressed during 3-AT, their identities are largely 
unique.  There were 20 probe sets (Fig. 10A), representing 16 identifiable genes, that 
were repressed in response to either stress arrangement (Fig. 10D and supplemental Table 
S5, (153), Gcn4p repression core).  These genes encode ribosomal proteins, as well as 
those involved in the mitochondria, intermediary metabolism, and protein processing.  It 
is interesting to note that only 53 of the genes repressed by rapamycin required GCN2 
(Table 4). Thus as noted above for 3-AT,  a large number of genes requiring Gcn4p for 
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regulation did not show significant requirements for GCN2, which would suggest an 
important role for basal amounts of Gcn4p for coordination of the transcriptome. 
Gln3p contributes to repression of 396 probe sets (Table 4), which represent 
genes involved in the same processes as described above for Gcn4p.  In fact 149 of the 
genes repressed by rapamycin require both Gcn4p and Gln3p (Fig. 10B).  This finding 
reinforces the idea that Gcn4p is a major effector of the TOR pathway, with this GAAC 
regulator contributing to gene repression, as well as activation in response to rapamycin.  
Relief of repression of these genes may be at least one reason for the growth resistance of 
gcn2Δ, gcn4 gln3Δ cells to rapamycin treatment (Fig. 7A) 
 
IV. The Gcn4p activation core (GAC) is induced by either 3-AT or rapamycin 
treatments 
Analysis of the overlap between genes induced in response to either 3-AT or 
rapamycin identified 68 and 66 genes that required GCN2 or GCN4, respectively, for full 
induction (Fig. 10A).  By contrast, far fewer (11 genes) required GLN3 for enhanced 
expression during both stress arrangements (Fig. 10A).  As will be discussed further 
below, the two additional genes that were dependent on GCN2, but not GCN4, were 
ARO9 and ARO10.  We refer to the 66 probe sets (57 identifiable genes) induced by 
either 3-AT or rapamycin treatment by a mechanism requiring Gcn4p as the Gcn4 
activation core (Fig. 10C and supplemental Table S3, (153)).  A total of 53 genes in the 
Gcn4p activation core contain at least one copy of a GCRE, with promoters of 46 
members previously shown to bind to Gcn4p in ChIP experiments (Fig. 10C) (156). 
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The Gcn4p activation core can be viewed as those genes whose expression is the 
foundation for GAAC-directed adaptation to different stress arrangements.  A large 
portion of these core genes participate in amino acid metabolism (23 of 57 genes, P  
2x10
-18
).  Most represented among these biosynthetic genes are those involved in the 
aromatic amino acids (ARO3, ARO8, TRP2, TRP3, and TRP4) and arginine (ARG2, 
ECM40 (ARG7), CPA1, CPA2, and ARG1) (Fig. 10C and supplemental Tables S2 and 
S3, (153)).  Other major functional categories are genes involved in nitrogen utilization 
(11 genes), a point that will be further discussed below, and those contributing to cellular 
transport (7 genes). One of these metabolism-related genes is BSC5 (YNR069C), which 
encodes the amino terminal portion of a coding region juxtaposed out-of-frame with a 
downstream ORF YNR068C.  Together these combined ORFs encode a predicted 
polypeptide with homology to Bul1p, an ubiquitin-binding protein that is important for 
sorting of amino acid permeases and growth during stress conditions (168). 
The Gcn4p activation core also includes three transcription factors: Gln3p, 
suggesting a regulatory intersection between the GAAC and TOR pathways; Stb4p, 
involved in histone deacetylation (169); and Uga3p, a zinc finger transcriptional activator 
of genes required for nitrogen assimilation from GABA (170).  The coordination of 
Gcn4p and Gln3p in GABA catabolism will be further addressed below.  Also part of the 
Gcn4p activation core is Pcl5p, a cyclin partner for the PHO85 protein kinase that is 
required for phosphorylation and subsequent feedback degradation of Gcn4p (74,171).  
Gcn4p induces the expression of two protein kinases genes, PKP2 and YDL025C (RTK1).  
Pkp2p inhibits mitochondrial pyruvate complex, which catalyzes the oxidative 
decarboxylation of pyruvate to acetyl-CoA (172).  This suggests that the GAAC restricts 
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carbon flux between glycolysis and the tricarboxylic acid cycle.  Rtk1p has been tied to 
glucose homeostasis and is closely related to the Hrk1p protein kinase that regulates 
plasma membrane transporters (173-174).  Finally, two TY elements and six probe sets 
which map to unannotated regions of the yeast genome are among the Gcn4p activation 
genes, suggesting that noncoding RNAs also contribute to Gcn4p-mediated stress 
responses.  
 
V. GAAC directs transcription of genes involved in assimilation of aromatic 
amino acids 
Our transcriptome analysis suggested that the GAAC is important for directing 
gene transcription involved in nitrogen assimilation, as previously reported for the TOR 
pathway.  Included among these genes are ARO9 and ARO10, which are required for 
reclamation of nitrogen from aromatic amino acids via the Ehrlich pathway (175).  As 
noted above, the microarray analysis showed increased expression of a small number of 
genes requiring Gcn2p in response to either 3-AT or rapamycin treatment, but these were 
largely independent of Gcn4p (Figs. 13A and B).  Microarray measurements were 
independently confirmed by quantitative RT-PCR of ARO9 and ARO10 transcripts and 
additional select mRNAs (Fig. 14). 
The transcription factor Aro80p is suggested to facilitate ARO9 and ARO10 
transcription (176).  We found that the levels of ARO80 mRNA were not significantly 
changed during either stress condition or in response to deletion of GCN2, GCN4, or 
GLN3 (supplemental Table S1, (153)).  Additionally, we measured expression of the 
ARO9 promoter (PARO9) fused to a lacZ reporter and found enhanced β-galactosidase 
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activity in response to either 3-AT or rapamycin, with the most robust increase during 
histidine starvation (Fig. 13C).  Loss of GCN2 resulted in a dramatic reduction in PARO9-
lacZ activity in both control and stress conditions.  This reporter assay supports the idea 
that the changes in ARO9 mRNA levels measured in our microarray analysis were the 
result of GAAC-directed transcription at the PARO9.  As expected, there was minimal 
PARO9-lacZ expression in cells deleted for ARO80 (Fig. 13C).  The induction of PARO9-
lacZ by 3-AT or rapamycin was observed only when amino acids were supplemented to 
the minimal medium, suggesting that cells recognize starvation signals and induce the 
expression of key catabolic enzymes only when their respective substrates are available 
in the media (Fig. 13C). 
These results suggest that the Gcn2p functions upstream or in a pathway parallel 
to Aro80p activation of genes that are important for catabolism of aromatic amino acids.  
Illustrating the key role of ARO80 in aromatic catabolism, deletion of ARO80 partially 
reduced growth in synthetic medium containing phenylalanine as the sole nitrogen source 
(Fig. 13D).  No reduction in growth was found when the aro80Δ cells were grown in 
synthetic medium containing the nitrogen source ammonia, or in medium containing all 
twenty amino acids. 
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Figure 13.  The GAAC and ARO80 are required for expression of aromatic 
catabolism genes.  Microarray measurements of ARO9 (A) and ARO10 (B) mRNA 
levels were measured in gcn2Δ, gcn4Δ, and gln3Δ cells, individually or in combination, 
which were treated with 3-AT or rapamycin, or no treatment (Control), as indicated.  
Transcript levels are plotted as mean fluorescence intensity (MFI).  Changes in ARO9 and 
ARO10 mRNA levels were confirmed independently by quantitative RT-PCR in Fig. 14.  
(C) Wild-type (WY837), gcn2Δ (WY838), and aro80Δ (WY962) strains containing a 
PARO9-lacZ reporter plasmid were cultured in synthetic complete medium with (+AA) or 
without amino acids (-AA), as indicated, and treated with 3-AT or rapamycin, or not 
treated (Control) for 6 hours.  β-galactosidase activity was measured from two 
independent cultures and is presented as the mean ± S.E.  (D) Prototrophic strains were 
grown on synthetic agar plates containing either ammonia (NH4
+
), all twenty amino acids 
(20 AA), or phenylalanine (Phe) as the nitrogen source, as indicated. 
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Figure 14.  qRT-PCR analysis of select transcripts in cells treated with 3-AT or 
rapamycin.  qRT-PCR measurements of select mRNAs were carried out in wild-type 
(WY798), gcn2Δ gcn4Δ gln3Δ (WY858) cells , deleted 
individually or in combination (WY859 and WY860).  Cells were treated with 3-AT or 
rapamycin, or no treatment (Control), as indicated in the legend.  Changes in transcript 
levels are expressed as fold-change relative to the untreated control in wild-type cells.  
The average fold-change from three to four independent experiments ± S.E. is shown. 
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Cells deleted for either GCN2 or GCN4 individually, or in combination with 
ARO80 were also cultured in these media.  All mutant strain combinations grew in 
medium containing all twenty amino acids. While deletion of GCN2 alone did not elicit a 
growth defect in synthetic medium containing ammonia or phenylalanine as the nitrogen 
source, the combined gcn2Δ aro80Δ strain selectively displayed a severe growth defect 
in the phenylalanine medium (Fig.13D).  Cells deleted for GCN4 often have growth 
defects in minimal medium supplemented with ammonia but no amino acids, presumably 
due to their reduced capacity to synthesize amino acids.  Interestingly, gcn4Δ cells grew 
to wild-type levels in synthetic medium supplemented with the nitrogen source 
phenylalanine (Fig. 13D).  As observed for gcn2Δ mutants, introduction of gcn4Δ into 
the aro80Δ strain exacerbated the growth defect in the phenylalanine medium.  These 
results indicate that the Gcn2p contributes to catabolism of aromatic amino acids via a 
pathway linked to Aro80p-directed transcription of ARO9 and ARO10.  As Gcn4p did not 
appear to be required for induced transcription of either ARO9 or ARO10, Gcn4p may 
contribute to growth in media containing phenylalanine as a nitrogen source by 
coordinating amino acid biosynthesis and related metabolic pathways. 
 
VI. Gcn4p and Gln3p stimulate GABA catabolism 
One of the target genes in the Gcn4p activation core is UGA3, which also is 
jointly regulated by Gln3p (Fig. 10C and Table 5).  Gcn4p is suggested to have an 
important role in nitrogen utilization, and UGA3 encodes a transcription factor that 
directs expression of UGA1, UGA2 and UGA4, which facilitate catabolism of GABA.  
Deletion of either UGA3 or UGA1 significantly blocked growth in minimal medium  
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TABLE 5.  Genes co-regulated by GCN4p and GLN3p 
 
Systematic 
Name
a
 
Gene 
Name 
Description 
YLL055W YCT1 High-affinity cysteine-specific transporter 
YKL050C  Protein of unknown function 
YKL218C SRY1 
3-hydroxyaspartate dehydratase, deaminates L-threo-3-hydroxyaspartate to form 
oxaloacetate and ammonia 
YDL170W UGA3 
Transcriptional activator necessary for gamma-aminobutyrate (GABA)-dependent 
induction of GABA genes 
YIR017C MET28 Transcriptional activator in the Cbf1p-Met4p-Met28p complex 
YIL165C  Putative protein of unknown function 
YIL164C NIT1 Nitrilase 
YHR029C YHI9 Protein of unknown function 
YGR087C PDC6 Pyruvate decarboxylase isozyme 
YER175C TMT1 Trans-aconitate Methyltransferase 1 
YER065C ICL1 Isocitrate lyase 
YDL032W  Hypothetical ORF 
YCL027W FUS1 Cell-surface protein required for cell fusion 
YBR147W RTC2 ORF, Uncharacterized 
YBR145W ADH5 Alcohol dehydrogenase isoenzyme V 
YPL033C SRL4 Putative protein of unknown function 
YPL092W SSU1 Major facilitator superfamily 
YOL058W ARG1 Arginosuccinate synthetase 
YNR068C  Putative protein of unknown function 
YNR069C BSC5 
Bypass of Stop Codon transcript encoded by this ORF shows a high level of stop 
codon bypass 
YNR044W AGA1 a-agglutinin anchorage subunit 
YNL145W MFA2 a-factor mating pheromone precursor 
YNL279W PRM1 
Pheromone-regulated multispanning membrane protein involved in membrane fusion 
during mating 
YMR323W ERR3 Protein of unknown function, has similarity to enolases 
a
Genes involved or suspected to be involved in nitrogen utilization are highlighted in 
bold. 
91 
 
 
92 
 
 
 
 
 
Figure 15.  Gcn4p and Gln3p co-regulate gene expression in response to rapamycin 
treatment.  (A) A wild-type strain, and those containing the indicated gene deletions, 
were grown on synthetic agar plates containing either ammonia (NH4
+
) or GABAas the 
nitrogen source for 3 days at 30 °C.  (B) Yeast cells deleted for GCN4, GLN3, and UGA3, 
as indicated, were transformed with a plasmid encoding a lacZ reporter gene fused to the 
UGA1 promoter.  Cells were cultured in synthetic medium containing ammonia (NH4
+
) 
as the nitrogen source, switched to synthetic medium containing 10 mM GABA as the 
nitrogen source for 6 hours, and β-galactosidase activity was measured.  The fold change 
in β-galactosidase activity over the cells grown in ammonia from two independent 
cu (C) β-galactosidase activity was measured in wild-type and 
gcn2Δ cells encoding PGCRE-lacZ, which were grown in synthetic medium containing 
ammonia as the nitrogen source in the presence (NH4
+
 + AA) or absence (NH4
+
) of all 
twenty amino acids.  Alternatively cells were treated with 200 nM rapamycin (NH4
+ 
+ 
Rap), or grown in medium containing GABA as the nitrogen source for 6 hours, as 
indicated.  (D) Wild-type and mutant cells containing a PGATA-lacZ reporter plasmid 
containing the consensus GATA element were grown and assayed as described in panel 
C. 
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containing GABA as the nitrogen source, but had no effect on growth in media 
containing ammonia (Fig. 15A).  By comparison, deletion of GLN3 showed a partial 
reduction in growth in GABA medium, while gcn2Δ cells showed wild-type levels of 
growth.  However when gcn2Δ and gln3Δ were combined, growth in GABA medium 
was reduced to levels comparable to cells deleted for UGA1 or UGA3 (Fig. 15A).  These 
results further support the idea that the GAAC and TOR pathways function together to 
regulate GABA catabolism.  Consistent with these findings, deletion of either GCN2 or 
GLN3 reduced UGA1 expression as measured by a lacZ reporter assay in response to the 
addition of GABA in the medium as the sole nitrogen source (Fig. 15B).  Combined 
GCN2 and GLN3 deletions led to a further lowering of PUGA1-lacZ expression, although 
this reduction did not equal that found in the uga3Δ cells (Fig. 15B).  These results 
suggest that the GAAC and TOR pathways function upstream of UGA3 in the regulation 
of UGA1 transcription in response to GABA. 
To more directly address the role of the GAAC in GABA catabolism, we assayed 
Gcn4p-transcriptional activation, as measured by the PGCRE-lacZ reporter, in GABA 
medium.  There was a marked increase in PGCRE-lacZ activity in the GABA medium 
compared to that containing ammonia (Fig. 15C).  GABA induction of Gcn4p 
transcriptional activity in fact exceeded that measured for rapamycin, and deletion of 
GCN2 significantly reduced PGCRE-lacZ activity in the GABA medium, as well as with 
rapamycin treatment.  Similar assays using a lacZ reporter expressed from a promoter 
containing GATA elements showed that GABA was also a potent inducer of this TOR-
targeted transcriptional activator, which in fact exceeded that measured following 
treatment with rapamycin (Fig. 15D).  Deletion of GLN3 partially reduced the PGATA-lacZ 
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activity in response to GABA medium or in response to the addition of rapamycin to 
synthetic medium containing ammonia.  Gat1p is another transcriptional activator in the 
GATA family that is induced by TOR, and gat1Δ cells showed a similar reduction in 
PGATA-lacZ activity, which was further exacerbated with the combined deletion of GLN3 
and GAT1 (Fig. 15D).  It is noted that while rapamycin and GABA media significantly 
increased PGATA-lacZ activity, treatment with 3-AT in fact led to a 50% reduction in 
PGATA-lacZ expression (153).  In our transcriptome analysis, loss of GLN3 significantly 
reduced the expression of 71 genes during 3-AT stress (Table 4).  This suggests that the 
TOR pathway per se is not repressed by 3-AT, but rather the basal activity of Gln3p is a 
contributor to the expression of these genes during the amino acid limiting conditions. 
 
VII. Gcn2p phosphorylation of eIF2α is induced in cells shifted to GABA medium 
We next addressed the underlying mechanisms facilitating activation of Gcn4p 
transcription in GABA medium.  Gcn2p phosphorylation of eIF2α was induced within 15 
minutes of transfer from synthetic medium supplemented with ammonia into that 
containing GABA (Fig. 16A).  Elevated eIF2α phosphorylation was accompanied by 
lowered translation initiation, as judged by a sharp decrease in polysomes, coincident 
with elevated monosomes, as judged by sucrose gradient centrifugation (Fig. 16B).  The 
gcn2Δ cells shifted to the GABA medium showed high levels of polysomes, supporting 
the idea the Gcn2 phosphorylation of eIF2α was required for this reduction in global 
protein synthesis.  Translational expression of GCN4, as measured by the GCN4-lacZ 
reporter, was significantly increased in response to GABA (Fig. 16C).  Consistent with  
95 
 
 
 
 
 
 
96 
 
 
 
 
 
 
 
97 
 
Figure 16.  Gcn2p phosphorylation of eIF2α reduces global translation and 
enhances GCN4 expression upon shifting to GABA medium.  (A) Wild-type (GCN2) 
and gcn2Δ cells were grown in synthetic medium lacking amino acids and containing 
ammonia (NH4
+
) as the nitrogen source and then switched to minimal medium containing 
GABA as the nitrogen source and grown for up to 120 minutes, as indicated.  As a 
control, GCN2 cells were grown in ammonia containing medium supplemented with 3-
AT for 60 minutes (GCN2 3-AT).  Levels of phosphorylated and total eIF2  were 
measured by immunoblot analyses. (B) GCN2 and gcn2Δ cells were grown in medium 
containing ammonia (NH4
+
) or shifted to GABA medium for 1 hour, and lysates were 
analyzed by sucrose gradient centrifugation.  The panels show the A254 profile of the 
gradients, with free 40 S and 60 S subunits, 80 S ribosomes, and polysomes indicated. 
The profile for the gcn2Δ cells grown in synthetic medium with ammonia was not shown, 
as it was unchanged from the wild-type cells cultured in this medium.  The ratio of 
polysomes (disomes or greater) compared to monosomes is illustrated above each panel.  
(C) β-galactosidase activity was measured from wild-type cells containing a GCN4-lacZ 
reporter plasmid with uORFs. Cells were grown in synthetic medium containing 
ammonia as the nitrogen source in the presence (+ AA) or absence (-NH4
+
) of all twenty 
amino acids, or were treated with 10 mM 3-AT (3-AT), 200 nM rapamycin (Rap), or 
grown in medium containing GABA as the nitrogen source for 6 hours, as indicated.  (D) 
β-galactosidase activity was measured from wild-type cells (WY837) containing a 
GCN4-lacZ reporter plasmid without uORFs (GCN4-ΔuORFs-lacZ).  Cells were grown 
in synthetic medium containing ammonia as the nitrogen source in the presence (+ AA) 
or absence (-AA) of all twenty amino acids, or were treated with 10 mM 3-AT (3-AT), 
200 nM rapamycin (Rap), or grown in medium containing GABA as the only nitrogen 
source for 6 hours.  The average β-galactosidase activity from two independent cultures is 
shown as the mean ± S.E.  (E) A low-copy plasmid p1025 encoding the GCN4 gene, with 
an encoded carboxy-terminal Flag epitope for detection by immunoblot, was introduced 
into the wild-type strain WY837.  This plasmid contains the wild-type GCN4 promoter 
and encoded GCN4 uORFs.  Cells were grown in synthetic medium with ammonia as the 
nitrogen source (0) or shifted to GABA medium for 1, 3, or 6 hours.  Alternatively, these 
cells were cultured in SD medium containing 3-AT for 6 hours, or in SC medium 
containing ammonia and all amino acids (NH4
+
 + AA).  For controls, the WY837 strain 
containing vector alone or p1025, which expresses the GCN4 gene devoid of uORFs 
expressed from a constitutive ADH promoter (GCN4
c
), were cultured in SD medium.  
Equal amounts of protein lysates were analyzed by immunoblot using Flag-specific 
antibody to visualize the tagged Gcn4p.  In the bottom panel, eIF2α protein was measured 
by immunoblot to show equal amounts of total protein were analyzed in each of the lanes. 
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the idea that the GAAC regulates translation via uORFs in the 5-leader of the GCN4 
mRNA, high levels of GCN4 expression were measured in cells containing a similar lacZ 
reporter devoid of the GCN4 uORFs independent of the stress treatment (Fig. 16D).  We 
also measured directly measured Gcn4p levels by immunoblot analysis and found 
accumulation of the Gcn4p beginning within 1 hour of shifting to GABA medium with 
maximum levels after 3 hours (Fig. 16E).  These studies support the idea that Gcn2p 
phosphorylation of eIF2α triggers both global and gene-specific translational control in 
the GABA medium. 
 
VIII. Sit4p facilitates GCN4 translation in GABA medium 
Gcn2p phosphorylation of eIF2α is essential for enhanced GCN4 translational 
control in GABA medium as viewed by the observation that gcn2Δ cells and cells 
containing an alanine substitution at Ser-51 in eIF2α (SUI2-S51A) displayed significantly 
lowered GCN4-lacZ reporter activity (Figs. 17A and B).  Sit4p protein phosphatase also 
contributes to activation of Gcn2p when TORC1 is repressed by rapamycin treatment.  
Consistent with an earlier report (14), the sit4Δ mutant suppressed GCN4 translational 
control in response to rapamycin treatment (Fig. 17C).  Importantly, deletion of SIT4 also 
reduced GCN4-lacZ expressed in response to GABA medium (Fig. 17C).  Together, 
these results are consistent with the idea that shifting to a secondary nitrogen source such 
as GABA relieves TOR-mediated repression of Gcn2p through a mechanism involving 
Sit4p protein phosphatase. 
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Figure 17.  Increased GCN4 translation by the alternate nitrogen source GABA is 
dependent on Gcn2p and Sit4p.  Wild-type (GCN2) and gcn2Δ (A), SUI2-SER51A (B),  
or sit4Δ (C) strains were cultured in synthetic medium lacking amino acids and 
containing ammonia (NH4
+
) as the nitrogen source and then switched to synthetic 
medium containing GABA as the nitrogen source and grown for 6 hours, as listed in the 
legend.  β-galactosidase activity was measured from the GCN2 and gcn2Δ cells 
containing a GCN4-lacZ reporter plasmid with uORFs (GCN4-uORFs-lacZ).  The 
average β-galactosidase activity from three independent cultures ± S.E. is shown.  In 
panel C, the fold-change for the different medium conditions as compared to the synthetic 
medium containing ammonia and all amino acids (NH4
+ 
+ AA) is indicated above each 
histogram. 
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IX. Increased deacylation of tRNAAsp and tRNAPhe in cells shifted to GABA 
medium 
Our studies suggest that repression of TORC1 contributes to activation of the 
GAAC in response to a shift from synthetic medium supplemented with ammonia into 
that containing GABA.  Elevated uncharged tRNA levels are also central to activation of 
Gcn2p.  To directly address whether the levels of tRNA charging are reduced upon a shift 
to GABA medium, we measured changes in charging of all tRNA species by a method 
involving tRNA microarrays that includes complementary probes to each chromosomal-
encoded tRNA (22).  A prototrophic strain, and its gcn2Δ counterpart, were shifted from 
SD medium to synthetic medium containing GABA for up to 120 minutes, and RNA was 
extracted under mild acidic conditions which retain aminoacylated tRNAs.  The RNA 
sample was split into two parts.  One half was subjected to periodate oxidation, 
destroying the 3’-ends of all uncharged tRNAs, while the other half served as a control 
and was not treated with periodate.  Both samples were then deacylated using alkaline pH 
and a fluorescent-tagged oligonucleotide was ligated onto only those tRNAs with intact 
3’-ends. Both samples were labeled with Cy3 or Cy5 fluorophore.  After fluorescent 
labeling, tRNA preparations with opposite fluorophores, for example charged tRNA with 
Cy5 and total tRNA with Cy3, were combined and hybridized to microarrays. 
The array results presented as histograms and heat maps showed the relative 
tRNA charging levels between cells shifted to GABA medium compared to the SD 
control (Fig 18).  Within 60 minutes of the shift of the wild-type cells to GABA medium, 
there was a significant reduction in the charging of tRNA
Phe
 and tRNA
Cys
 , along with a 
more modest reduction in tRNA
Trp
 (Figs. 18A-C).  These tRNA charging levels were  
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Figure 18.  Increased uncharged tRNA levels in cells shifted to GABA medium. The 
protrophic strain WY798 and isogenic gcn2Δ counterpart (WY799) were cultured in SD 
medium and then shifted to synthetic medium containing GABA as the sole nitrogen 
source for 15, 30, and 120 minutes. The charging of tRNA genome-wide was measured 
by the microarray method.  (A) Scanned flourescent images of tRNA
Phe
 hybridized to the 
complementary probe in the microarrays.  The tRNA preparations were cultured in SD 
medium (0 min) or GABA medium for 120 minutes (120 min). Yellow represents no 
change in the charging of tRNA
Phe
 and green indicates low tRNA charging.  (B) The 
relative levels of tRNA charging are presented as the ratio of each charged tRNA 
prepared from the wild-type strain cultured in GABA medium for 60 minutes compared 
to those cultured in SD medium.  The x axis lists each of the different tRNAs, collated 
into hydrophobic, small, charged and polar groups.  The value of 1.0 in the y axis 
indicates that the tRNA charging in cells cultured in GABA is equal to that in the SD 
control.  Values less than 1.0 indicate reduced tRNA charging, while values greater than 
1.0 denote tRNA charging that is greater upon shift of the cells to GABA medium.  Error 
bars represent ± S.E.  (C) Heat map representations of genome-wide tRNA charging in 
response a shift to GABA medium.  The levels of tRNA charging were measured in the 
GCN2 and gcn2Δ strains upon shifting to GABA medium for 15, 60, and 120 minutes.  
Those cells that were shifted to SD medium as a control are represented as 0.  Green 
indicates decreased tRNA charging in the GABA medium compared to the SD control, 
while red represents enhanced tRNA charging, as listed on the scale to the right of the 
figures.  (D) Northern blot analysis of acid-denaturing gels measuring the charging of 
tRNA
Phe
 in the GCN2 and gcn2Δ strains upon shifting the cultures from SD medium to 
GABA medium for up to 120 minutes, as indicated. The panels include an autoradiogram 
representing hybridization of a radiolabeled probe complementary to charged (slower 
migrating band) and uncharged (faster migrating band) tRNA
Phe
.  As a control, the 
tRNA
Phe
 was deacylated prior to the Northern analysis (+) and compared to samples that 
were not subjected to deacylation in vitro prior to the Northern analysis (-).  (E) Strain 
RY139 (gcn2 a GCN4-lacZ reporter with uORFs 
intact was transformed with a low-copy plasmid encoding GCN2, mutant gcn2-m2, or 
vector alone.  Cells grown in synthetic medium containing ammonia as the nitrogen 
source (NH4
+
) were treated with 10 mM 3-AT (NH4
+
 + 3-AT) or 200 nM rapamycin 
(NH4
+
 + Rap), or grown in medium containing GABA (GABA) as the nitrogen source for 
6 hours.  The average β-galactosidase activity measured from three independent cultures 
± S.E. is shown. 
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further diminished with culturing in this medium for 120 minutes (Fig. 18C). The gcn2Δ 
strain showed a different pattern of charging genome-wide, with increased deacylation of 
tRNA
Cys
, tRNA
Lys
, tRNA
Pro
, in both the SD and synthetic GABA medium (Fig 18C).  
Upon shifting to the GABA medium there were additional reductions in tRNA charging 
levels, including that of the initiator tRNAi
Met
. 
The reduced charging of tRNA
Phe
 in the wild-type cells was confirmed by 
Northern analysis (Fig. 18D).  The tRNA preparations subjected to deacylation in vitro 
showed uniformly uncharged tRNA
Phe
, presented as the faster migrating band.  The 
tRNA
Phe
 was charged at >75% in SD medium, with progressive reductions in charging 
levels upon shifting to the GABA medium, and with the greatest degree of deacylation at 
120 minutes.  The charging levels of tRNA
Phe
 were retained in the gcn2Δ cells cultured in 
SD and the synthetic GABA medium. 
The enhanced levels of uncharged tRNA suggests that induced Gcn2p 
phosphorylation of eIF2α upon shifting to the GABA medium involves Gcn2p binding to 
uncharged tRNA, along with TORC1 signaling.  To further address the role of activation 
of Gcn2p by uncharged tRNA in response to the shift to the GABA medium in vivo, we 
measured induction of GCN4 translational control in cells containing a mutant version of 
GCN2 (gcn2-m2) that contains missense mutations previously shown to block binding to 
uncharged tRNA.  We reasoned that if uncharged tRNA is central for activation of Gcn2p 
in response to a shift to synthetic GABA medium, that mutations that blocked Gcn2p 
binding to uncharged tRNA would thwart activation of the GAAC.  Indeed we found that 
gcn2-m2 mutation blocked enhanced GCN4-lacZ expressed in response to GABA 
medium (Fig. 18E).  These findings suggest that enhanced levels of uncharged tRNA 
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contribute to activation of Gcn2p and the GAAC upon shifting from SD to synthetic 
GABA medium. 
 
X. Gcn4p and Gln3p activate UGA3 transcription 
Our transcriptome studies suggested that Gcn4p and Gln3p activate UGA3 
transcription in response to stress, and therefore the role of the GAAC and TOR 
pathways is to coordinate the transcription of UGA1, and other GABA catabolic genes.  
This idea is further supported by our observation that expression of a lacZ reporter fused 
to the UGA3 promoter (PUGA3) was increased in response to rapamycin or 3-AT treatment 
(Fig. 19A).  Deletion of either GCN2 or GCN4 significantly lowered UGA3 transcription 
in response to either stress.  By comparison, loss of GLN3 lowered PUGA3-lacZ expression 
only during rapamycin exposure, with no change in the 3-AT medium (Fig. 19A).  There 
are four predicted Gln3p binding sites in the PUGA3 region, and two Gcn4p binding 
elements (Fig. 19B).  To determine the minimum elements in the PUGA3 required for 
enhanced transcription in response to 3-AT or rapamycin stress, a processive 5'-deletion 
analysis was carried out in the PUGA3-lacZ reporter.  Removal of the most 5'-elements, 
including two Gln3p-binding sites and a single Gcn4p-binding element, in the PUGA3-300-
lacZ reporter construct did not significantly reduce transcription in response to either 3-
AT or rapamycin treatment (Fig. 19B).  Further deletion of the Gln3p binding site in the 
PUGA3 lowered β-galactosidase activity by 2-fold during rapamycin treatment, but had no 
effect in response to 3-AT.  Importantly, removal of the lone GCRE blocked UGA3 
transcription in response to either stress condition, suggesting that Gcn4p binding to the 
PUGA3 region is central for increased UGA3 transcription (Fig. 19B). 
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Figure 19.  Gcn4p and Gln3p co-regulate the UGA3 promoter.  (A) A PUGA3-lacZ 
reporter plasmid was introduced into wild-type cells, or cells deleted for GCN2, GCN4, 
and GLN3, individually or in combination, as indicated.  Cells were cultured in synthetic 
complete medium supplemented with all amino acids except histidine, treated with 3-AT, 
rapamycin (Rap), or no treatment (Control) for 6 hours, and β-galactosidase activity was 
measured.  The average β-galactosidase activity from two independent cultures ± S.E. is 
shown.  (B) Wild-type cells containing a lacZ reporter gene under the control of the 
UGA3 promoter (-677) or deletions of the UGA3 promoter (-371, -300, -200, or -103), as 
indicated, were cultured and treated as in panel A.  Predicted Gln3p and Gcn4p binding 
sites in the UGA3 promoter are indicated.  (C) The consensus Gln3p (GATA) and Gcn4p 
(GCRE) binding sites present in the minimal UGA3 promoter at -206 and -112, 
respectively, were mutated by site-directed mutagenesis, as indicated.  Wild-type cells 
containing a lacZ reporter gene under the control of the wild-type minimal UGA3 
promoter (-300), a minimal promoter containing a mutant Gln3p (GATA) and Gcn4p 
(GCRE) binding sites, individually or in combination, as indicated were cultured and 
treated as described in panel A.  (D) Wild-type cells containing PUGA3-lacZ reporter genes 
as described in C were cultured in synthetic medium containing ammonia as the nitrogen 
source in the presence (NH4
+
 + AA) of all twenty amino acids, absence (NH4
+
) of all 
twenty amino acids, or grown in medium containing GABA as the nitrogen source as for 
6 hours, as indicated.  (E) Model depicting the role TOR-mediated regulation of Gln3p 
and Gcn4p activity in regulation of UGA3 mRNA expression and subsequent utilization 
of GABA as a nitrogen source in yeast. 
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To further address the roles of the Gcn4p and Gln3p-binding elements in UGA3 
transcription, these elements were mutated individually or in combination in the proximal 
-300 version of the of the PUGA3-lacZ reporter, which retained maximal transcription in 
response to either 3-AT or rapamycin (Fig. 19C).  Consistent with our deletion analysis, 
mutations in the Gcn4p binding element blocked PUGA3-300-lacZ expression in response to 
either stress condition.  By comparison, alteration of the Gln3p binding element partially 
lowered PUGA3-300-lacZ activity in response to rapamycin. 
We also addressed whether these two binding elements are important for UGA3 
transcription when GABA is the sole nitrogen source in the medium.  The PUGA3-300-lacZ 
reporter were assayed in cells cultured in medium containing ammonia and a complete 
complement of amino acids, or medium devoid of amino acids and only GABA as the 
nitrogen source. GABA medium led to an 8-fold increase in PUGA3-300-lacZ activity (Fig. 
19D).  Mutations in either the Gcn4p or the Gln3p binding element significantly reduced 
PUGA3-300-lacZ expression in GABA medium.  Therefore, Gcn4p and Gln3p are central for 
increasing UGA3 transcription in response to a variety of nutrient stresses. These findings 
support the idea that Gcn4p is a major transcriptional effector of the TORC1 pathway, 
and that this regulatory pathway has an important role in the assimilation of secondary 
nitrogen sources, such as GABA (Fig. 19E). 
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DISCUSSION 
I. Central questions addressed in this microarray study 
This study addressed the regulatory linkages between the GAAC and TOR 
pathways in directing the transcriptome in response to amino acid starvation and 
rapamycin treatment.  Three central questions were addressed.  The first central question 
is whether the transcriptome directed by Gcn4p in response to amino acid depletion is 
similar to that in rapamycin treatment, or can different stress conditions allow for 
significant variations in the Gcn4p-directed transcription?  We found that there is a core 
of 57 genes that are activated by Gcn4p in response to either stress condition; these 
included genes involved in amino acid biosynthesis, nitrogen utilization, signaling, and 
gene expression (Fig. 10C).  Among these core genes, we focused on the relationship 
between the GAAC and nitrogen utilization. Specifically, we delineated the underlying 
mechanisms by which Gcn4p facilitates GABA utilization and the processes contributing 
to the activation of the GAAC upon shifting to this secondary nitrogen source.  These 
results indicate that the GAAC has a focal set of genes that are central for cellular 
adaptation to different stresses.  Gcn4p and the GAAC also retain versatility to direct 
stress-specific gene expression, as illustrated by the large collection of genes induced 
specifically by 3-AT or rapamycin treatment (Fig. 10A).  The Gcn4p-targeted genes 
activated specifically by histidine depletion emphasized amino acid and intermediary 
metabolism, while those induced by rapamycin included generation and utilization of 
energy-related compounds (supplemental Tables S2 and S3, (153)). 
The second central question concerned the role of Gcn4p in TOR-directed gene 
expression and the mechanisms underlying the regulatory linkages between the GAAC 
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and TOR pathways.  Importantly, we found that Gcn4p is a major transcriptional effector 
of the TOR pathway, with the number of genes requiring Gcn4p for activation in 
response to rapamycin treatment being similar to that dependent on the canonical Gln3p 
transcription factor (Table 4).  In response to rapamycin, Gcn4p induced genes involved 
in amino acid biosynthesis, intermediary metabolism, and transport processes.  
Furthermore, analogous to the TOR pathway, Gcn4p targets many genes that are central 
for nitrogen utilization. 
The GAAC and TOR pathways intersect at multiple points to regulate the 
transcriptome.  Rapamycin inhibition of TORC1 is suggested to reduce inhibitory 
phosphorylation of Gcn2p by activating type 2A-related protein phosphatases, such as 
Sit4p, and by inhibiting an unknown protein kinase (14).  Our study suggests that the 
shift to a secondary nitrogen sources, such as GABA, is a physiological condition that 
releases TORC1 inhibition of Gcn2p and the GAAC.  We propose that there is a dual 
mechanism regulating the GAAC upon shifting to GABA medium.  Gcn2p activation can 
occur by both the release of TOR repression of Gcn2p and activation of this eIF2α kinase 
by uncharged tRNAs that accumulate in response to a shift to a secondary nitrogen 
source.  We found that a shift to GABA medium led to significant deacylation of tRNAs 
(tRNA
Phe
 and tRNA
Cys
) (Fig. 18), which is suggested to also contribute to activation of 
Gcn2p by direct binding to this eIF2α kinase.  It is noted that deletion of GCN2 alters the 
pattern of accumulated uncharged tRNA (Fig. 18C).  In the gcn2Δ cells grown in 
synthetic medium containing ammonia there were significant levels of many different 
uncharged tRNAs, including tRNA
Asp
, tRNA
Cys
, tRNA
Lys
, tRNA
Pro
 and tRNA
Tyr
.  This 
finding suggests that loss of Gcn2p creates a deficiency in the amino acid biosynthetic 
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pathways that can lead to significant levels of different deacylated tRNAs.  Interestingly, 
upon shifting the GCN2-deficient cells to GABA, there continued to be significant levels 
of uncharged tRNA, albeit the pattern was modified compared to the wild-type strain 
(Fig. 18C). 
Additional points of intersection occur downstream in the TOR and GAAC 
pathways. The Gcn4p activation core includes GLN3, suggesting that activation of the 
GAAC can increase Gln3p activity at least under some nutrient conditions (Fig. 10C).  
Therefore, the requirement for Gcn4p for stress-induced expression of some genes may in 
indirect.  The transcriptional activators Gcn4p and Gln3p also can coordinately induce 
transcription of target genes, such as UGA3, by binding at different elements within their 
respective promoters (Fig. 19E). 
The third central question is whether Gcn2p can regulate the transcriptome 
independent of Gcn4p or vice versa?  The predominant picture is that genes requiring 
Gcn2p for induction in response to either rapamycin or 3-AT were also dependent on 
Gcn4p. These results support the model in which the primary role of Gcn2p in yeast is to 
enhance Gcn4p expression in response to stress.  Included among those genes requiring 
Gcn2p for activation in response to both 3-AT and rapamycin are ARO9 and ARO10 
(Figs. 13A and B).  Both genes are central for catabolism of aromatic amino acids, and 
interestingly their induced mRNA expression was independent of GCN4.  However, 
deletion of either GCN2 or GCN4 led to a significant growth defect in medium containing 
phenylalanine as the sole nitrogen source when combined with aro80Δ (Fig. 13D).  These 
results suggest that although Gcn4p is not directly involved in ARO9 and ARO10 
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transcription, Gcn4p contributes to the metabolic conditions required for assimilation of 
aromatic amino acids. 
It is also noteworthy that almost a third of the genes targeted by Gcn4p displayed 
significantly reduced requirements for Gcn2p, suggesting that basal levels of Gcn4p 
retain important biological functions (Table 4).  This idea is consistent with the findings 
that the gcn4Δ cells have a growth defect in the absence of supplemented amino acids, 
while loss of GCN2 in an otherwise prototrophic strain does not have a phenotype in SD 
medium devoid of amino acids (Fig. 13D).  Analogous to Gcn4p, the basal activity of 
Gln3p is also suggested to have activating functions in the transcriptome.  This was 
illustrated in cells treated with 3-AT, where 71 genes required Gln3p for full induction 
(Table 4).  However, 3-AT in fact did not lead to any increase in the expression of the 
PGATA-lacZ reporter (153).  This suggests that the basal activity of Gln3p is a significant 
contributor to the transcriptome during amino acid starvation, although the precise 
mechanisms are currently unclear.  Supporting this idea is the finding that deletion of this 
transcription factor reduces growth in 3-AT containing medium (Fig. 8A). 
 
II. Gcn4p directs different transcriptome programs in response to diverse 
stresses 
Our microarray analysis identified a collection of genes, designated the Gcn4p 
activation core (GAC), which are transcriptionally induced during either amino acid 
starvation or rapamycin treatment. Gcn4p can also increase the expression of additional 
genes that are unique to the specific stress (Table 4).  Currently, we understand only 
general mechanistic schemes for how Gcn4p can delineate between core and stress-
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specific gene transcription.  Gcn4p activation of transcription is largely thought to be a 
consequence of its increased concentration in the cell, which involves translational 
control induced by eIF2α phosphorylation and its turnover, triggered by Pho85p/Pcl5p 
(73,171,177).  Elevated levels of Gcn4p lead to its enhanced binding at the GCREs in the 
promoters of its target genes, which then serves to recruit different co-activators that 
facilitate association with RNA polymerase II (178). 
For stress-specific gene transcription, one anticipates additional mechanisms for 
controlling Gcn4p activity, or supplementary transcription factors that interact with the 
promoters of a subset of Gcn4p-targeted genes and are regulated by alternative stress 
pathways.  Supporting the idea that additional mechanisms contribute to Gcn4p activity, 
we found that GABA induction of Gcn4p transcriptional activity in fact exceeded that 
measured for other stresses, 3-AT and rapamycin, despite there being a more moderate 
inducer of GCN4 translational control (Figs. 15C and 16B).  Regarding supplemental 
transcription factors, we showed that Gcn4p and Gln3p were required for full induction 
of 24 different genes during rapamycin stress, including regulation of the UGA3 promoter 
in response to rapamycin treatment, as well as during a shift to GABA medium (Table 5 
and Figs. 19C and 19D).  Cooperation between Gcn4p and a second transcription factor, 
which can be regulated independent of the Gcn4p and the GAAC during certain stresses, 
would facilitate variations in the transcriptome.  Many of these central concepts 
concerning Gcn4p and stress-specific gene expression are germane to the transcriptome 
induced by eIF2α phosphorylation in mammalian cells subjected to different stress 
arrangements, such as those influenced by nutrient deficiencies or unfolded proteins 
(10,179-181). 
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Gcn4p was also shown to be required for repression of a number of genes in 
response to 3-AT or rapamycin, with 16 genes constituting the so-called Gcn4p 
repression core (Fig. 10D and supplemental Table S5, (153)).  The mechanism by which 
Gcn4p contributes to repressed transcription is not understood.  It has been proposed that 
elevated levels of Gcn4p may squelch the transcription of certain target genes by binding 
to and impeding the function of key co-activator proteins, therefore compromising the 
induction of these target genes (82,182).  Interestingly, many of these Gcn4p repression 
core genes have GCREs in proximity to their promoters, which suggests that Gcn4p 
repression may result through direct DNA binding.  Gln3p contributed to ≥2-fold 
repression of an even greater number of genes compared with Gcn4p (396 versus 197 
genes, Table 4 and supplemental Table S2 (153)).  The underlying mechanisms for Gln3p 
repression are also not clear.  It has been suggested that Gln3p repression of transcription 
of amino acid biosynthetic genes may be indirect through imbalanced changes in the 
expression of permease genes that facilitate nutrient uptake (183).  We note that many of 
the genes requiring GLN3 for repression have identifiable GATA elements in their 
promoters (supplemental Table S5, (153)), suggesting that Gln3p may repress selected 
promoters by direct binding. 
 
III. TOR regulates the GAAC to facilitate utilization of secondary nitrogen 
sources 
Our study suggests that TOR regulation of the GAAC is central for adaptation to 
secondary nitrogen sources in the medium.  Introduction of GABA as a nitrogen source 
enhances Gcn2p phosphorylation of eIF2α, leading to increased Gcn4p translation and 
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transcriptional activity (Figs. 15C, 16A, C, and D).  Supporting the idea that GABA 
activation of Gcn2p is facilitated through inhibition of TORC1 is the finding that GABA 
induces Gln3p activity (Fig. 15D), and that GABA induction of GCN4 mRNA translation 
is diminished by loss of Sit4p (Fig. 17C), which is similar to that reported for rapamycin 
treatment (14).  By contrast, amino acid starvation elicited by 3-AT does not lead to 
repression of TORC1, as judged by only diminished Gln3p-directed transcription during 
this stress condition, and activation of Gcn2p in response to 3-AT does not require Sit4p 
(14). 
Together, these results support a model in which dual mechanisms contribute to 
activation of Gcn2p and the GAAC in response to changes in nutrient availability.  In the 
first mechanism, amino acid deprivation, such as that elicited by 3-AT, increases the 
levels of uncharged tRNA.  Elevated levels of uncharged tRNA would then directly bind 
to the HisRS-related domain of Gcn2p, resulting in enhanced Gcn2p phosphorylation of 
eIF2α (Fig. 20).  The second mechanism would occur when yeast cells are shifted to 
medium containing certain secondary nitrogen sources, such as GABA.  Repression of 
TORC1 upon shifting to GABA medium can induce eIF2α kinase activity by a 
mechanism consistent with release of inhibitory phosphorylation of Gcn2p (Fig. 20).  
This release of Gcn2p inhibitory phosphorylation would involve the signaling pathway 
including TAP42 and the type 2A protein phosphatases encoded by SIT4 and the SIT4-
associated protein (SAP) genes. 
Uncharged tRNA is also suggested to be an activating ligand for Gcn2p in GABA 
medium, therefore TORC1 signaling and Gcn2p binding to uncharged tRNA appear to 
work in combination to enhance Gcn2p phosphorylation of eIF2α in response to a shift to 
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secondary nitrogen sources.  It is noteworthy that phosphorylation of eIF2α occurs within 
15 minutes of a shift from SD to synthetic GABA medium and is retained after 120 
minutes (Fig. 16A).  However, significant deacylation of tRNA
Phe
 and tRNA
Cys
 occurs 
after culturing for 1 hour in the GABA medium (Fig. 18C).  The timing of these events 
suggests that the two mechanisms may contribute at different periods during the course of 
activation of Gcn2p.  A central feature in this mechanism of activation is that the TORC1 
and Gcn2p protein kinases are reciprocally regulated in response to changes in nitrogen 
source, which would contribute to their opposing control of protein synthesis and Gcn4p 
activation (Fig. 20). 
Godard and colleagues have also suggested a role for Gcn4p and the GAAC in 
nitrogen catabolism (159).  In this earlier study, transcriptome measurements were 
carried out in the yeast Σ1278b strain grown in minimal medium containing one of 21 
different nitrogen sources.  The majority of these nitrogen sources were classified into 
two different groups, an A group of nitrogen compounds that supported rapid growth, and 
a B group of nitrogen sources that supported only slow growth.  Growth in the group B 
nitrogen compounds, including many different amino acids (leucine, isoleucine, 
methionine, threonine, tryptophan, and tyrosine) led to increased expression of many 
genes linked with Gcn4p.  These results suggested that the GAAC is activated in yeast 
cultured in medium with poorer nitrogen sources.  In fact many of the genes induced 
during culturing in media with group B nitrogen compounds were included in the Gcn4p 
activation core, as listed in the genes highlighted in blue text in Fig. 10C (supplemental 
Table S3 (153)).  In addition to GABA catabolism, we found that the GAAC facilitates  
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Figure 20.  The role of the general amino acid control pathway in TOR-regulated 
gene expression.  Model depicting the role of GAAC in TOR-regulated gene expression 
including genes in the Gcn4p-dependent activation core and repression core.  The top 
right panel illustrates a model wherein enhanced Gcn2p activity contributes to elevated 
Gcn4p transcriptional function.  Conversely, TOR signaling serves to repress the GAAC, 
with elevated Gcn4p function occurring with lowered TORC1 activity. 
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nitrogen assimilation of aromatic amino acids, by a mechanism involving activation of 
ARO9 and ARO10 transcription (Figs. 13A-C). 
A role for Gcn4p in nitrogen catabolism was also suggested by Gonzalez and 
colleagues, who were the first to show that GCN4 translation can be induced by 
rapamycin (16).  Gcn4p was suggested to contribute to the transcription of Gln3p-
targeted genes, DAL1 and DAL5, which are important for uptake and degradation of the 
nitrogen source allantoin, and for UGA3, a focus of this study (16,184).  These findings 
further support the idea that the transcription of genes involved in nitrogen assimilation 
can be coordinately regulated by Gcn4p and Gln3p, as illustrated in Fig. 19E. 
 
IV. Future Directions 
This work discovers that there are new changes in the yeast transcriptome 
following amino acid starvation or inactivation of the TOR signaling pathway with 
rapamycin and these findings raise several interesting questions.  First, while we show 
that Gcn4p functions to induce the transcription of a core set of genes, the GAAC retains 
the ability to increase gene expression in a stress-specific fashion.  How does Gcn4p 
attain this specificity?  As described in this dissertation, one possible mechanism is that 
Gcn4p functions coordinately with other transcription factors, such as Gln3p to increase 
transcription of genes involved in the utilization of secondary nitrogen sources such as 
GABA.  It is possible that Gcn4p functions in conjunction with additional transcription 
regulators to achieve stress-specific induction of genes expression. A second possible 
mechanism contributing to the specificity of Gcn4p transcriptional activity involves post-
translational modifications that may change the expression of Gcn4p-targeted genes.  
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Gcn4p is known to be phosphorylated on multiple residues and subject to ubiquitin-
mediated degradation (73,171,177).  Whether or not these Gen4p control processes are 
regulated in response to stress is not known. Along these lines, we noted a significant 
increase in Gcn4p transcriptional activity in the absence of Gcn2p protein kinase 
following growth in the alternative nitrogen source GABA (Fig. 15C).  Experiments to 
address the effects of stress on DNA binding versus the activation function of Gcn4p may 
shed light on whether stress-specific signaling plays a role in Gcn4p function. 
In addition to UGA3, several uncharacterized genes were shown to be co-
regulated by Gcn4p and Gln3p (Table 5).  These include YKL050C, YIL165C, YHR029C, 
YDL032W, RTC2, YNR068C, and YMR323W.  It is tempting to speculate that many of 
these genes might play a role in nitrogen metabolism.  Gene deletion experiments 
followed by growth tests in the presence of alternative nitrogen sources could be carried 
out to address this possibility. 
In addition to its role in the activation of transcription, Gcn4p contributes to the 
repression of genes involved in protein synthesis such as ribosomal protein genes, as well 
as genes involved in protein folding, targeting, and sorting, and processing.  We have 
noted that several of these genes containing recognizable GCRE motifs in their promoter 
regions.  Whether or not direct DNA binding by Gcn4p in the context of these promoters 
contributes to gene repression is not known, and it would be of interest to address the 
underlying mechanisms by which the GAAC can directly or indirectly repress 
transcription. 
 
 
123 
 
V. Summary 
The experiments described in this dissertation attempt to address three central 
questions underlying the integration of the GAAC and TOR signaling pathways.  First, is 
the transcriptome directed by Gcn4p in response to amino acid starvation similar to that 
in response to inactivation of the TOR signaling pathway by rapamycin treatment, or do 
different stress conditions allow for significant variations in GCN4p-directed 
transcription?  While we found a large number of genes induced by either 3-AT or 
rapamycin treatment, a core set of 57 genes was shown to be activated by Gcn4p by 
either stress condition.  The GAC included genes involved in amino acid biosynthesis, 
nitrogen utilization, signaling, and gene expression.  These results indicate that the 
GAAC has a focal set of genes that are central for its biological function in response to 
different stresses, but Gcn4p also retains versatility to direct stress-specific gene 
expression as illustrated by the large collection of genes induced specifically by 3-AT or 
rapamycin treatment (Fig. 10A). 
The second question addressed in this dissertation concerns the nature of the 
regulatory linkages between the GAAC and TOR pathways.  The GAAC and TOR 
pathways can intersect at multiple points to regulate the transcriptome.  In response to 
rapamycin treatment, we find that Gcn4p is a major transcriptional effector of the TOR 
pathway, with the number of genes requiring Gcn4p being similar to that dependent on 
the canonical Gln3p transcription factor (Table 4).  Like the Gln3p-directed 
transcriptome, Gcn4p targets many genes that are central for nitrogen utilization.  
Rapamycin inhibition of TORC1 is suggested to reduce inhibitory phosphorylation of 
Gcn2p by activating type 2A-related phosphatases, such as Sit4p, and by inhibiting an 
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unknown protein kinase (14).  Our study suggests that the addition of secondary nitrogen 
sources, such as GABA, to the medium releases TORC1 inhibition of Gcn2p and the 
GAAC.  Growth in GABA medium also increased uncharged tRNA thus TORC1 
signaling and binding of uncharged tRNA to Gcn2p appear to act in concert to 
phosphorylate eIF2α (Fig. 18).  A second point of intersection occurs downstream in the 
TOR and GAAC pathways.  The transcriptional activators Gcn4p and Gln3p can 
coordinately increase the transcription of target genes, such as UGA3, by binding at 
different UAS elements within their respective promoters (Fig. 19E). 
The third question addressed in this work is whether Gcn2p can regulate the 
transcriptome independent of Gcn4p?  With few exceptions, the genes requiring Gcn2p 
for induction in response to either rapamycin or 3-AT were also dependent on Gcn4p.  
These results support the model in which the primary role of Gcn2p in yeast is to enhance 
Gcn4p expression in response to stress.  Conversely, almost a third of the genes targeted 
by Gcn4p displayed significantly reduced requirements for Gcn2p, suggesting that basal 
levels of Gcn4p retain important biological functions (Fig. 10A, Table 4, and 
supplemental Table S1 (153)).  This idea is consistent with the findings that the gcn4  
cells have a growth defect in the absence of supplemented amino acids, while loss of 
GCN2 in an otherwise prototrophic strain does not have a phenotype in SD medium 
devoid of amino acids.  Like Gcn4p, the basal activity of Gln3p is also suggested to have 
activating functions in the transcriptome. 
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